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ŒNEEIAL INTRODUCTION 
Pasteurella multocida (P. multocida) is a Gram-negative bacterium 
capable of infecting most animal species including man. Capsular type A 
and scmatic type 3 strains of the microorganism are known to be a major 
etiological factor of pneumonic pasteurellosis of cattle, and econcmic 
loss to the U.S. cattle industry from the disease exceeds a half billion 
dollars annually. The scientific and economic importance of £. multocida 
has led to the development and use of various bacterins for prevention; 
however, the efficacy of these products has been questioned. In fact, 
immunization of cattle with Pasteurella bacterins has been demonstrated 
to be detrimental to the health of the animal. The questionable efficacy 
and safety of bacterins has led to experimentation with various 
subcellular fractions of the microorganism in studies of bacterial 
pathogenesis and in pursuit of a better immunogen. 
Lipopolysaccharides (LPS, endotoxin) present in the outer membrane 
of Gram-negative bacteria have been demonstrated to play important roles 
in bacterial infection of animals. The £. multocida LPS extracted by 
conventional methods (phenol-water, phenol-chloroform-petroleum ether or 
trichloroacetic acid) has been observed to evoke a variety of endotoxic 
activities in a host including pyrogenicity, depression, diarrhea and 
death in mice, rabbits and chickens, and lethality for chicken anbryos. 
Although LPS extracted by the phenol-water method was poorly immunogenic, 
many researchers suggested that £. multocida fractions with demonstrated 
immunogenicity contained the LPS as a part of their constituents. 
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Previously, we have reported that a fraction isolated from a 
potassium thiocyanate (KSCN) extract of a P. multocida organism (strain 
P-2383; capsular type A and somatic type 3) induced resistance in mice 
against a challenge with the homologous bacterium. The fraction, called 
P-2383-1, was determined to be a LPS-protein complex since it contained 
27% protein and serologically crossreacted with the LPS extracted by the 
phenol-water method. However, 2-keto-3-hydroxy-octonate (KDO), which is 
an important constituent of Gram-negative bacterial LPS, was not detected 
in P-2383-1. 
The outer surface of Gram-negative bacteria contains several 
distinctive structures including the outêr membrane, capsule, glycocalyx, 
fimbriae and flagella. Exopolysaccharides, the outer membrane and the 
cell wall may be extremely complex and. variant among bacterial species. 
This complexity contributes to a major problan in the extraction and 
characterization of individual structural components. Also, different 
extraction methods yield variant products; the basic components may be 
the same but the nature of complexes can be diverse. This variation 
extends to previous experimentation on P. multocida and may account for 
the diversity of products reported by individual investigators. 
Our previous experimentation on P-2383-1 failed to demonstrate the 
presence of KDO in this complex. However, we were convinced that this 
was probably due to a limited quantity of this material and an 
insensitivity of the assay procedure. This problan is not unique to our 
experimentation and similar problems have been observed in other 
immunogenic fractions of P. multocida such as a free endotoxin, a 
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particulate material and a LPS-protein complex. The potential for LPS to 
serve in immunogenic capacities such as the protective determinant or as 
an adjuvant necessitated further characterization of this immunogenic 
complex. 
The objective of this experimentation was to further characterize 
the chemical composition and biological activities of the LPS-protein 
complex. Specific aims were; 1) to determine the chemical composition of 
P. multocida LPS in comparison with the chemical composition of LPS of 
several Gram-negative bacterial pathogens, 2) to characterize the LPS-
protein complex isolated from the KSCN extract of P. multocida and 3) to 
examine the immunologic reactivity of the LPS-protein complex in mice. 
An alternative format is used for this dissertation. Literature 
cited in each manuscript is listed at the end of each manuscript while 
references cited both in the literature review and individual manuscripts 
are included in "Literature Cited" at the end of the dissertation. 
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LITERATURE REVIEW 
Genus Pasteurella multocida 
History 
A disease process now known as pasteurellosis was reported long 
before the isolation of the causative microorganisms. During the 18th 
century, large epornitics in poultry were reported throughout European 
countries and were first studied in France by Chabert in 1782 (47) . 
Maillet in 1836 termed the disease fowl cholera in connection with severe 
losses of fowl (47) . 
Renault and Delafond, in the middle of the 19th century, presented 
the first experimental evidence of the transmissibility of the disease by 
the injection of the infected blood, secretions and tissues into poultry 
(52). The presence of a bipolar staining, non-motile organism in the 
blood of affected birds was first reported by Rivolta in 1877 and 
Perroncito in 1878 (52). Toussaint confirmed these observations in 1879, 
was the first to isolate the microorganism from the blood of an affected 
chicken, and cultivated it in neutralized urine (47) . Pasteur in 1880 
grew the bacterium in pure culture in chicken broth and examined the 
virulence and immunological properties of the microorganism in chickens 
(52). He observed that chickens which recovered frcxn the disease or were 
immunized with aged live bacteria, which were found to be avirulent for 
chickens, were protected against a lethal challenge dose of fresh-
cultured, live, virulent microorganisms. However, the immunity could be 
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overwhelmed by a large challenge dose of bacteria. 
After isolation of the bacterium from birds, many investigators 
found that this organism was a very versatile pathogen capable of 
infecting cattle, buffalo, sheep, swine, rabbits, horses, cats, dogs, 
rats and mice (83). Moore in 1895 found the organism on the mucous 
membrane of the respiratory tract of apparently normal cattle, sheep, 
swine, dogs and cats (14). The importance of the bacterium in human 
infection was recently recognized in relation to infected animal bites 
(38) . 
The isolation of different strains from multiple animal hosts by 
various individuals and at different times resulted in a variety of terms 
being suggested to name this microorganism (83). Kitt in 1885 suggested 
the term Bacterium bipolar multocidum to name the bipolar organism on the 
basis of its infectivity for a variety of hosts. Trevisan in 1887 used 
the name "Pasteurella" in honor of Pasteur and listed 3 species: P. 
cholerae-gallinarum, P. davainei and P. suilla. Flugge in 1896 related 
the organisms to species by names such as Bacillus boviseptica. Bacillus 
suiseptica and so on. These classifications represent the early tendency 
to form a species name on the basis of the affected host. In following 
this procedure in detail, Lignieres listed species names, such as 
Pasteurella bovine for wild animal, buffalo and cattle strains, £. 
aviaire for avian strains, P. ovine for sheep strains, P. porcine for pig 
strains, etc. Since all of the strains of the organisms isolated from 
the different animals were so similar in their morphology and cultural 
characteristics, an inclusive name was suggested again as a consequence 
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of the trend to use one name for a variety of strains. The name 
Pasteurella septica suggested by Topley and Wilson in 1936 was employed 
widely in some European countries. The name Pasteurella multocida 
proposed by Rosenbusch and Merchant in 1939 (104) has acquired almost 
universal recognition at the present time. 
Characteristics 
According to Bergey's Manual of Systematic Bacteriology (80), P. 
multocida belongs to the family Pasteurellaceae (genera Pasteurella, 
Haemophilus and Actinobacillus) of the facultative anaerobic Gram-
negative bacteria. Organisms from infected animal tissues usually appear 
as coccobacilli or short rods (1.4 _+ 0.4 by 0.4 + 0.1 um) with non-motile 
and bipolar staining properties. Strains isolated from healthy animals 
are often pleomorphic with longer bacillary forms and are occasionally 
short filaments. With electron microscopic examination of the organism, 
Brogden (12) observed small spherical blebs and filamentous appendages on 
the surface of the cell. P. multocida can be distinguished from other 
Pasteurella species (P. haemolytica, P. gallinarum, P. aerogens, P. 
pneumotrophica, P. ureae) by the following characteristics: hemolysis on 
blood agar -, growth on MacConkey agar -, growth in lactose -, growth in 
mannitol +, indole production +, urease activity - and gas production 
from carbohydrates - (80). 
Many isolates of P. multocida possess a capsule which usually can be 
detected by Jasmin's procedure, the Alcian blue method, India ink 
staining (22), or a negative staining method (12) . The amount and 
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chemical nature of the capsule seans to vary greatly from isolate to 
isolate. Carter's type A organisms possess the largest capsules that 
give the colonies a mucoid appearance (23). The capsule is composed, to 
a large extent, of hyaluronic acid (23, 25) that serves as a framework 
for the attachment of polysaccharides, proteins and lipids (22). Some 
type D P. multocida also possess a hyaluronic acid capsule, but the 
amount is quantitatively much less than type A. (23) . Carter's type B and 
E organisms also possess a capsule but the chemical nature is a 
glycoprotein rather than hyaluronic acid, an acid-mucopolysaccharide (5, 
23). 
Typing systans 
Methods for grouping and classification of multocida were 
extensively reviewed by Cornelius in 1929 (33) , Carter in 1967 (22) and 
Brogden in 1977 (12) . According to the review by Cornelius, early 
workers tried to establish a serological classification of the bacteria 
which corresponded to the zoological grouping. Matsuda in 1910 
considered that a complement fixation test verified the zoological 
classification of pig, fowl, rabbit and calf strains. Miesser and Schern 
in 1910 found no agglutinatory relationship between ovine strains and 
other animal strains. Fitch and Nelson in 1923 could not demonstrate 
correspondence between a serological and a zoological grouping. Tanaka 
in 1926 used complement fixation methods and demonstrated the 
heterogeneous nature of the zoological groups in this respect. Lai in 
1927 found sctne evidence of cross-reactivity among different animal 
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strains by application of a conplanent fixation test. 
Cornelius (33) classified 17 of 26 strains into 4 groups by use of 
agglutinin-absorption tests and found no relationship between a 
serological group and the animal origin of the strains. In 1934, Ochi 
examined 72 hemorrhagic septicemia strains isolated from various species 
of animals and divided than into 4 groups on the basis of serological, 
immunological and pathological properties (12). Like Cornelius, he found 
that there was no relationship between his groups and the host of origin. 
Rosenbusch and Merchant in 1939 (104) identified 3 serologically 
distinctive types among 114 non-hemolytic Pasteurella strains by 
agglutinin tests and the ability of the microorganisms to ferment xylose, 
arabinose and dulcitol. Little and Lyon in 1944 (72) confirmed the 
existence of 3 serologically distinct types within 30 non-hemolytic 
Pasteurella strains by passive immunization of mice and agglutination 
tests. They found that type specificity, virulence and host origin of 
these strains were unrelated. Roberts in 1947 (103) divided P. multocida 
strains into four groups, I, II, III and IV, on the basis of serum 
protection tests in mice. 
Carter (18) observed that £. multocida possesses a type specific 
capsular antigen, presumably polysaccharide in nature. He prepared the 
capsular antigen from several serologically distinctive strains of P. 
multocida by 2 methods: (1) Bacteria grown on an agar plate were 
suspended in buffered saline and heated at 56 C for 1 h after 
centrifugation, the bacterial pellet was discarded and the supernatant 
fluid was collected, and (2) bacteria grown on an agar plate were treated 
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with 1 M sodium acetate and ethanol followed by subsequent extraction 
with phenol and saline. He also iitmunized rabbits and chickens with 
0.25% formalized saline-treated bacteria to obtain the type specific 
antisera. By the use of the two extracted antigens and type specific 
antisera in precipitation tests, he determined that there appeared to be 
a type specific polysaccharide antigen consisting of, or associated with, 
the capsule. Based on his studies, he identified 3 capsular types, A, B 
and C among strains of P. multocida. Later, an additional type D was 
demonstrated by Carter and Byrne (24) by the same methods. 
Carter (19) applied an indirect hemagglutination test for typing the 
bacteria. By the use of his capsular antigen preparations, immune sera 
and erythrocytes of human 0 blood type for the test, he found that this 
technique yielded highly specific reactions and had advantages over other 
typing methods. The type C designation was subsequently dropped because 
of difficulties in recognition (19) . An additional type E, which was 
isolated in Central Africa and closely related to type B strains, was 
suggested later (21). 
Heddleston et al. (53) introduced a gel-diffusion precipitation test 
for serotyping avian isolates of P. multocida. They prepared P. 
multocida bacterins from 5 serologically distinctive strains (an 
extension of a proposal by Little and Lyon) to immunize chickens for the 
preparation of type specific antisera. Typing antigen was obtained from 
bacteria suspended in 0.85% NaCl solution containing 0.3% formaldehyde 
and heated in a water bath at 100 C for 1 h. The supernatant fluid 
obtained by centrifugation of the suspension was designated a heat-stable 
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serotyping antigen. They found that the heat-stable antigen of one 
serotype reacted only with the homologous serum in gel-diffusion 
precipitation tests. On the basis of the experiments, they reported that 
at least 5 different serotypes could be differentiated by this test. 
This serotyping system was further studied (11, 54) and is now composed 
of 16 serotypes (12). 
Several non-serological typing methods for specific serotypes of P. 
multocida strains were suggested for the support of the previous typing 
systans. Carter and Annau (23) found that the capsule of type A strains 
contains a large amount of hyaluronic acid which endows colonies with a 
mucoid appearance. The mucoid appearance of the colony was changed by 
treatment with staphylococcal hyaluronidase which depolyraerizes the 
hyaluronic acid polymer of the capsule. By use of this method, type A 
strains could be identified non-serologically (25) . Carter and Suboronto 
(26) identified type D strains non-serologically by the use of an 
acriflavine reaction that showed a coarse flocculation only with type D 
strains in a slide agglutination test. 
At present, the most widely used methods for typing P. multocida 
organisms are Carter's method for capsular typing and Heddleston's method 
for soTiatic typing. 
Relationship of serotypes to diseases 
There has been difficulty in correlating somatic serotypes of 
multocida organisms with diseases in animals; however, correlations were 
found in Carter's capsular types of the bacterium with geographical 
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distribution, hosts and types of diseases (22) . Strains of capsular 
types A and D are distributed widely in the world and cause primary and 
secondary infections. The clinical syndrome is primarily respiratory 
disease in a wide range of animal species including cattle, swine, 
chicken, turkey, cat, dog, rabbit, sheep, mouse and man (20, 22). 
Strains of capsular type B cause hemorrhagic septicemia essentially 
confined to cattle, bison and water buffalo, and geographically 
distributed in tropical areas (24). Strains of capsular type E cause 
hemorrhagic septicemia in cattle in Central Africa (21). 
The most important serotype of P. multocida in animal diseases in 
North America appears to be Carter's capsular type A and Heddleston's 
somatic type 3. Strains of capsular type A £. multocida are known to 
cause pneumonic pasteurellosis in cattle .and fowl cholera in chickens and 
turkeys (14, 22) and economic loss due to the diseases-has been great in 
animal industries of the United States (14, 22, 52, 82, 83). According 
to an epidemiological study by Blackburn et al. (11) , somatic type 3 was 
most frequently isolated in the United States accounting for 60% of the 
cattle and 57% of the chicken and turkey isolates. If isolates 
containing serotype 3 specificity such as serotypes 3 and 4, 3 and 12, 
and 3, 4 and 12 were included, more than 96% of the cattle and 80% of the 
chicken and turkey isolates had serotype 3 specificity. 
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Pneumonie Pasteurellosis in Cattle 
Occurrence of pneumonic pasteurellosis 
Pneumonic pasteurellosis is a common and serious complication of the 
respiratory disease complex of cattle characterized by fever, nasal 
discharge, coughing and various forms of pneumonia followed in sane cases 
by death (1, 21, 132). The economic loss to the U.S. cattle industry 
from the disease exceeded a half billion dollars annually according to a 
report from the United States Department of Agriculture (82) . Studies on 
etiology of the disease have indicated that the disease may be the result 
of the complex interaction or cumulative effect of viruses, bacteria, 
mycoplasma, chlamydia and environmental factors (7, 28, 39, 105, 106). 
However, the most important etiologic agents are currently known to be 
Pasteurella haemolytica (P. haemolytica) and P. multocida since these 
organisms are most consistently and frequently isolated from the lungs of 
cattle with severe respiratory disease (27, 28, 39, 45, 60, 61, 81). 
Although P. multocida is reported to be less involved than P. haemolytica 
in acute shipping fever pneumonia of feedlot cattle (39, 125, 132), P. 
multocida has been isolated more frequently than P. haemolytica in the 
southern part of U.S.A. from cases of pneumonic pasteurellosis (16, 28). 
Isolations are most common from weanling calves a few weeks to a few 
months old and from cases of chronic pneumonia in feedlot and adult 
cattle (27, 60, 125, 132). 
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Pathogenesis of pneumonic pasteurellosis 
Bacterial colonization in the lower respiratory tract of healthy 
animals including cattle is a relatively rare event. However, in 
individuals suffering from a variety of diseases or environmental stress, 
colonization occurs frequently (7, 40). Studies on human respiratory 
diseases indicated that the colonization is the first step in the 
development of pneumonia (3, 8). The increased colonization of the 
oropharynx with Gram-negative bacteria has been correlated with changes 
in the surface properties and surrounding environments of the epithelial 
cells lining the upper respiratory tract (9, 116, 117, 129) . These 
changes apparently allow large numbers of bacteria to adhere to the 
epithelial cells and replicate at a faster rate. Once a large quantity 
of bacteria are present in the upper respiratory tract, the bacteria can 
enter the lung by aspiration (62) or as a result of reduced mucociliary 
clearance (58) . 
The entrance of bacteria into the lung does not always produce 
pneumonia since small numbers of Pasteurella organisms introduced into 
the lung by intratracheal or transthoracic injection were rapidly cleared 
by the local defense system of the lung (41). This indicates that 
bacterial colonization of the lung is a prerequisite for production of 
the disease. It has been suggested that several mechanisms may be 
involved in the increased bacterial colonization of the lung. The 
increased rate of bacterial adherence and replication in the upper 
respiratory tract may result in production of microcolonies which then 
enter the lung (69). If these microcolonies are enclosed by mucus or 
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bacterial glycocalyx, they will be more difficult to phagocytize than an 
individual bacterium and will be resistant to attack by antibiotics and 
surfactant including antibodies (34, 36, 69). Viral infections of 
phagocytic cells such as alveolar macrophages and neutrophils may result 
in defects of host cellular defense mechanisns. Infected alveolar 
macrophages and neutrophils exhibit decreases in their phagocytic 
activities such as chanotaxis, ingestion, phagosome-lysosome fusion, 
lysosome levels and cytokine production (59, 96, 105, 109, 126). 
P. multocida can ranain localized in the upper respiratory tract of 
healthy cattle for a long time but for seme reason, the level or degree 
of growth is limited and the animal does not exhibit any ill effects (7). 
The mechanisms for colonization of P. multocida in the upper respiratory 
tract of cattle followed by movement down the trachea into the lung and 
subsequent production of pneumonia are presently not known. However, 
characteristics of the P. multocida bacterium in addition to other 
microbial infections and environmental stress were suggested to be the 
most important aspect of the pathogenesis (32, 45, 71). 9. multocida is 
known to produce neuraminidase that breaks down mucus, thus making the 
mucus less viscous (89) . The role of this enzyme in aiding bacteria to 
reach the lung is not well defined, but, in the gut, it has been shown 
that Vibrio cholera mutants deficient in this enzyme are less virulent 
than the parent organian (40). multocida is also known to produce 
endotoxin (22) that has a wide array of toxic effects in experimental 
animals. Although the role of P. multocida endotoxin in pneumonic 
pasteurellosis of cattle has not been studied, many Gram-negative 
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bacterial endotoxins were reported to initiate complément and coagulation 
cascades in hosts (63, 85, 91, 110, 115). The result was increased 
vascular permeability and coagulation leading to accumulations of 
inflammatory cells, edema and both intravascular and extravascular fibrin 
in the lung (58, 123). The best studied pathogenic mechanism of P. 
multocida infection in cattle is the role of the P. multocida capsule 
which allows the bacterium to escape the phagocytic defense mechanism of 
the host. Maheswaran and Thies (79) examined the influence of 
encapsulation on phagocytosis of P. multocida by bovine neutrophils by 
using two encapsulated strains, NA77 (capsular type A) and C42 (capsular 
type B), and one unencapsulated strain 1173. When they measured the 
uptake of [^ H]thymidine-labeled bacteria in the presence of normal bovine 
serin, the encapsulated strains inhibited the phagocytic activity of 
bovine neutrophils while the unencapsulated strain did not. C42 
(capsular type B) could be completely phagocytized by the neutrophils in 
the presence of hyperimmune anti-C42 serum. However, only 3.8% of the 
NA77 (capsular type A) bacteria were ingested by the neutrophils in the 
presence of hyperimmune anti-NA77 serum. When they treated NA77 
organisms with bovine testicular hyaluronidase, 90% of the decapsulated 
organisms were ingested. Therefore, they concluded that the factor 
associated with MA77 organism which inhibited the phagocytic activity of 
neutrophils was probably hyaluronic acid which is a major component of 
the capsule of type A £. multocida. We have previously examined the 
effect of various type A P. multocida fractions from two encapsulated 
strains on bovine polymorphonuclear leukocyte (PMN) functions (108) . 
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Ingestion of bacteria and halogenation of the ingested bacteria by PMNs 
were inhibited in the presence of live cells, heat-killed cells or 2.5% 
saline extracted surface material but not in the presence of décapsulated 
heat-killed cells. None of the bacterial fractions inhibited oxidative 
metabolism by PMNs. The PMN inhibitory factor was characterized as a 
heat-stable surface material of greater than 300,000 molecular weight. 
Treatment of this material with hyaluronidase did not destroy the 
inhibitory activity and hyaluronic acid isolated from human umbilical 
cord did not suppress PMN function. Therefore, it has been suggested 
that the capsular hyaluronic acid may not be the inhibitory factor 
although the PMN inhibitory factor may be structurally linked to the 
bacterial hyaluronic acid. 
Attanpts to prevent pneumonic pasteurellosis in cattle 
The importance of P. multocida in pneumonic pasteurellosis has led 
to the development and use of various bacterin products for immunization 
of cattle. Palotay et al. (93) tested several biological preparations in 
an attempt to prevent respiratory infection in newly weaned beef calves. 
Of these products, three agents that significantly reduced mortality 
were; (1) a commercial hemorrhagic septicemia bacterin, (2) a bivalent 
bacterin prepared fran P. multocida and P. haemolytica strains, and (3) a 
formalinized bacterin prepared from chicken embryo-grown P. haemolytica 
which was isolated from cattle that died from acute pneumonia. However, 
there was still a 9.38% incidence of disease in the most effectively 
protected group as compared with a 21.05% morbidity in the control 
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groups. 
Hamdy et al. (50) examined the efficacy of 5 different commercial 
Pasteurella bacterins in young calves under field conditions. Although 
immunized calves showed as much as 500 times greater antibody titer than 
the controls, none of these bacterins effectively reduced the incidence 
of the disease. 
Larson and Schell (70) compared the toxicity of Pasteurella 
bacterins with their potential protective value in calves undergoing the 
stress of weaning and shipping. Calves given the bacterin developed 
significantly higher antibody titers than the controls. However, the 
immunized calves developed fever and leukocytosis with neutrophilia, 
although these effects were transient and did not clinically alter their 
general state of health when compared with the non-vaccinated controls. 
Bennett (10) examined the efficacy of commercial Pasteurella 
bacterins for yearling feedlot cattle. He found that the mortality rate, 
though not statistically significant, was increased in vaccinated calves. 
Although P. multocida bacterins have proven efficacy in experimental 
animals (17, 29, 57, 133) , these field trials indicated that the use of 
bacterins in cattle to prevent pneumonic pasteurellosis did not reduce 
the incidence of the disease significantly. In fact, it may be 
detrimental to the health of the animal. This questionable efficacy and 
safety of Pasteurella bacterins in cattle has led to examination of 
various subcellular fractions of the organism for the development of a 
better immunogen and for the study of their roles in bacterial 
pathogenesis. 
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Subcellular Fractions of Type A Pasteurella multocida 
Capsular antigens 
Carter and Annau (23) isolated capsular polysaccharides from the 
colonial variants of a P. multocida strain. The agar-grown bacteria were 
suspended in distilled water and heated at 56 C for 1 h, followed by 
centrifugation at 10,000 rpm. The supernatant fluid obtained by 
centrifugation was treated with 95% ethanol containing 0.25% sodium 
acetate. The precipitated polysaccharides from the fluorescent variant 
were found to induce a high level of protection in mice. Those of the 
mucoid variant were not protective. When the surviving mice were 
challenged with strains of other serological types, there was no 
protection. 
Kodama et al. (66) extracted a capsular material from a multocida 
strain by treating the organisms at 56 C for 1 h with 2.5% NaCl solution. 
This saline extract induced protective immunity in turkeys and chickens. 
A precipitate was obtained from the saline extract by treating it with 
cetylpyridiniun chloride. This precipitate was not immunogenic. By 
continuing studies on the extract, Syuto and Matsumoto (120) demonstrated 
electronsicroscopically that treatment of type A P. multocida cells with 
2.5% NaCl solution ranoved the capsule of the organism without disrupting 
the cell membrane. They fractionated the saline extract by gel-
filtration on a Sephadex G-200 column and obtained 4 different peaks. 
When the immunogenicity of the 4 peaks was evaluated in turkeys, the 
protective activity was detected only in the first peak. They further 
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purified the protective antigen present in the first peak by absorbing it 
onto DEAE-cellulose and eluting with a linear gradient of NaCl solution. 
They found that the purified protective antigen had a 
carbohydrate/protein ratio of 1.5 and formed a single precipitin line 
with a rabbit antiserum against the original saline extract in gel-
diffusion and immunoelectrophoresis. Upon sodiim dodecyl sulfate 
polyacrylamide gel electrophoresis, the purified antigen showed 4 bands. 
By isoelectric focusing analysis, it showed two bands. Each band of the 
isoelectric focusing analysis was isolated and used to immunize turkeys. 
However, neither of the two components, alone or in combination, induced 
protection in turkeys. 
Ganfield et al. (43) tried to purify a protective component(s) from 
a saline extract of a P. multocida strain. The starting material was 
obtained frcm the saline (0.85% NaCl containing 0.1% formalin) extract of 
2" multocida cells by differential centrifugation at 105,000 x g, and 
further purified by gel-filtration on Sepharose 2B. Three fractions were 
obtained after gel-filtration. The first fraction consisted of 10% of 
the starting material and was immunogenic in mice (80% protection). The 
second fraction consisted of 75 to 95% of the starting material and doses 
of 10 to 20 ug induced active iimunity in mice and turkeys. Large doses 
were found to be lethal. The third fraction was much less effective in 
inducing a protective immune response. 
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Lipopolysaccharide (LPS) antigens 
Rebers et al. (100) examined the serological and immunological 
properties of a purified LPS antigen isolated from an encapsulated strain 
of P. multocida. A crude LPS obtained by phenol-water extraction 
contained nucleic acids and capsular polysaccharides as well as LPS. The 
crude LPS was further purified by treatment with ribonuclease and 
deoxyribonuclease, followed by centrifugation at 165,000 x g for 3 h. 
The purified LPS was fractionated by CsClg density gradient 
centrifugation at 90,000 x g for 70 h and 3 visible bands were obtained. 
The middle band contained most of the LPS. The crude LPS and the middle 
band (1 to 10 ug) were used to immunize chickens to produce antisera. 
Passive administration of antiserum against the crude LPS protected 18% 
of the chickens. However, passive administration of antiserum against 
the middle band protected 86% of the chickens. Antisera obtained from 
the surviving chickens gave a single precipitation line in gel-diffusion 
with the homologous Heddleston's serotype antigen (12), and no reaction 
was obtained with any of the other 15 serotype antigens. Therefore, they 
concluded that P. multocida LPS is an important serological marker in 
Heddleston's typing system and antibodies induced against the LPS 
contribute to the protection of chickens. 
Rebers and Heddleston (98) compared the chemical and immunogenic 
properties of phenol-water extracted LPS (PW-LPS) with free endotoxin 
isolated from a P. multocida strain. The free endotoxin, which is 
secreted fran or loosely bound to the surface of £. multocida organism, 
was obtained by washing the agar-grown bacteria with cold 0.85% NaCl 
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solution containing formalin followed by centrifugation and gel-
filtration on a Sepharose 2B colunn. The free endotoxin induced active 
immunity in mice, but the PW-LPS did not. Although the PW-LPS and the 
free endotoxin both contained nitrogen, phosphorus, heptose and hexose, 
the free endotoxin had more nitrogen. Vigorous mixing of the free 
endotoxin or whole cell preparation with 50% phenol at roan temperature 
and subsequent dialysis to remove phenol resulted in complete loss of 
ability to induce active immunity in mice. Since most polysaccharides 
are stable to phenol and most proteins are irreversibly denatured by it, 
it would appear that some form of protein is necessary for the induction 
of active immunity against P. multocida infection. 
Particulate antigens 
Heddleston et al. (56) isolated a particulate antigen from two 
virulent and serologically distinctive strains, X-73 (somatic type 1) and 
P-I059 (somatic type 3), of £. multocida. The agar-grown bacteria 
suspended in formalinized saline solution were incubated for 48 h at 4 C 
followed by centrifugation for 30 min at 12,000 x g. The supernatant 
fluid was filtered through a 400-mesh nylon cloth. The filtrate was 
centrifuged for 2 h at 105,000 x g. A gel-like pellet obtained by the 
centrifugation was washed and designated a particulate antigen. The 
particulate antigens of the two strains possessed many of the properties 
ascribed to endotoxins. It was a high molecular weight, nitrogen-
containing, phosphorylated LPS. Injection of 100 to 500 ug of the 
antigen intravenously into mice, rabbits or chickens produced severe 
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effects on these animals such as depression and diarrhea; death followed. 
Almost 100% of the chickens given either intravenous injections of saline 
suspended particulate antigens in a dose of 2 ug or subcutaneous 
injection of the antigens emulsified in mineral oil were protected 
against a challenge of live homologous organisms Wiich killed 100% of the 
controls. The same degree of protection was obtained in mice. Good 
passive protection (90 to 100%) was obtained in mice with rabbit 
antiserum to the particulate antigen of X-73; however, antiserum to the 
particulate antigen of P-1059 induced only 0 to 40% protection. 
Potassium thiocyanate extracts 
Bain (5) used a potassium thiocyanate (KSCN) solution to extract 
surface materials from a capsular type B P. multocida strain. To a dense 
suspension of bacteria in normal saline there was added an equal volume 
of 1 M KSCN solution, followed by incubation at 37 C for 5 h. The 
bacterial suspension was centrifuged and the supernatant fluid was 
dialyzed against distilled water. Gaunt et al. (44) prepared a KSCN 
extract from a serotype 3 P. multocida strain (P-1059) by the method of 
Bain (5). The KSCN extract was found to be immunogenic in chickens 
against a challenge infection of the homologous strain as well as one 
heterologous strain tested (serotype 1, X-73). Gel-diffusion analysis 
revealed the presence of two components which were antigenically 
identical in KSCN extracts of both serotypes. 
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Mukkur (87) immunized mice with the KSCN extract of P. haemolytica 
serotype 1. These mice were found to resist a challenge infection of a 
type A £. multocida strain, thus demonstrating cross-protection between 
the two Pasteurella species. This finding was further supported by the 
finding that P. multocida organisms could be killed by incubation with 
guinea pig complement and an antiserum directed against the KSCN extract 
of P. haemolytica, and vice versa. Mukkur (88) further compared the 
immunizing efficiency of his KSCN extract with a formalin-killed P. 
multocida bacterin prepared from the same organism in mice. All of the 
mice immunized with the KSCN extract survived a challenge dose of 1.6 x 
10^  cells. All of the mice immunized with the bacterin survived a 
challenge dose of 15 cells, but the survival rate decreased with 
increasing challenge dose. With a challenge dose of 1.5 x 10^  cells, 
only 10% of the immunized mice survived. When a combination of the KSCN 
extract and the bacterin were used to immunize mice, the survival rate 
was no better than that of mice inrounized with the bacterin alone. 
Bactericidal titers present in the sera of mice immunized with the 
extract were ten times higher than those in sera of mice irmiunized with 
the bacterin. Three times higher titers were present in the sera of mice 
immunized with the extract compared with those given the bacterin plus 
the extract. Based on the results, they suspected that immunosuppression 
might conceivably be due to antigenic competition or partial denaturation 
of some vital protective antigen(s) as a result of formalin treatment. 
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We have further evaluated immunogenicity and cross-protectivity of 
KSCN extracts in mice (107) . Mice immunized with KSCN extracts frcxn 
several P. multocida strains showed signs of depression for several hours 
after immunization but were protected against a challenge with the 
virulent homologous bacterium. However, there was no consistent 
reciprocal protection between different strains of a serotype indicating 
no correlation between serotype and cross-protection of mice. A 
component was isolated fron the KSCN extract by centrifugation of the 
extract at 87,000 x g for 18 h in a sucrose density gradient of 5 to 40% 
(wt/vol). A single antigenic component was isolated from the bottom half 
of the gradient. Serologic examination and chemical analysis indicated 
that this component is a LPS-protein complex. Immunization of mice with 
this fraction demonstrated resistance to challenge with the homologous 
strain and seme degree of protection against certain heterologous 
strains. 
Culture filtrate 
Srivastava et al. (113) canpared the immunogenicicty of the culture 
filtrate, cell walls and cytoplasmic components of a type A P. multocida 
strain, and tried to isolate a protective component(s) from the culture 
filtrate. The culture filtrate was prepared by centrifugation of 
bacterial cultures at 10,400 x g for 1 h followed by filtering the 
supernatant fluid through a 0.45 um membrane filter. The sediment 
obtained from the previous centrifugation was ruptured in a Ribi cell 
fractionator followed by centrifugation at 105,000 x g for 1 h. The 
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sediment was designated as cell wall and the supernatant fluid was 
filtered through a 0.45 urn membrane filter. The filtrate was designated 
as cytoplasm. The cell walls induced more protection in mice than 
cytoplasm or culture filtrate. They fractionated the culture filtrate on 
a Sephadex G-50 column and obtained 4 fractions. The first fraction was 
found to contain a protective material responsible for the protection of 
mice and was more immunogenic than cell walls. They indicated that this 
material is different from the free endotoxin studied by Heddleston and 
Rebers (55) , because it had very low levels of 2-keto-3-deoxy-octonate 
and heptose which are principal chemical components of the endotoxin. 
Srivastava and Foster (112) continued to study the first fraction 
obtained fran column chromatography. They treated it with ether to yield 
a "glycolipid-like" material and with phenol to yield a "LPS-like" 
material. They found that the ether-treated material was more 
protective for mice than the first fraction of the culture filtrate. 
However, the phenol-treated material was not immunogenic in mice and was 
toxic by rabbit skin tests. 
Ribosomal fractions 
Baba (4) examined the immunogenicity of a ribosomal fraction 
isolated from a P. multocida strain. Organisms grown in a liquid medium 
were harvested and washed by centrifugation. The packed cells were 
suspended in a Tris-HCl buffer, pH 7.4, followed by rupture in a French 
press. The ruptured cellular mass was centrifuged at 8,000 x g for 40 
min to remove whole cells, cellular debris and cell walls. The 
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supernatant fluid was further purified by differential centrifugation, 
zonal electrophoresis and gel-filtration on a Sephadex G-200 column. The 
ribosomal fraction exhibited intense protective irrmunogenicity in mice 
and turkeys. Sodium deoxycholate treatment of the ribosoraal fraction 
resulted in a 13% loss in iirmunological activity and ribonuclease 
treatment caused a 60% loss of the activity. Purified ribosomal protein 
or ribonucleic acid were not immunogenic in mice. 
Phillips and Rimler (94) prepared ribosomes from P. multocida, 
Brucella abortus, Aspergillus fumigatus and chicken liver by gel-
filtrating the chemically-lysed cells in a Sepharose CL-2B column. The 
purified ribosomes did not protect chickens against challenge exposure 
with a virulent strain of multocida (X-73, serotype 1). However, 
substantial numbers of chickens were protected when microbial ribosomes 
were fixed to homologous LPS extracted by the phenol-water procedure. 
When these immunized chickens were challenged with a heterologous strain 
with different serotype (P-1702, serotype 5), there was no protection. 
Therefore, they suggested that protection of chickens by ribosomal 
vaccine fron P. multocida infection depends on hanologous LPS. 
Importance of lipopolysaccharide-protein complex 
LPS of many Gram-negative bacteria, called endotoxin, is known to 
cause a variety of toxic effects in hosts such as pyrogenicity, 
lethality, Swartzman reaction, bone-marrow necrosis, leukopenia, 
leukocytosis, hypotension and abortion (63, 75, 85, 115) . LPS of P. 
multocida also exhibited many such toxic effects in hosts (6, 22, 95); 
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however, studies on subcellular fractions of P. multocida indicated that 
many fractions with danonstrated immunogenicity contained 
lipopolysacchaides in a LPS-protein complex. The £. multocida fractions 
containing the LPS-protein complex included a conponent isolated from a 
2.5% NaCl extract by Syuto and Matsumoto (120) , a component isolated from 
a 0.85% NaCl extract by Ganfield et al. (43), LPS-containing materials of 
Bain and Knox (6), Rebers et al. (99) and Rebers and Heddleston (98) , a 
particulate material of Heddleston et al. (56) and a component isolated 
from a culture filtrate by Srivastava et al. (113) , a conjugated LPS-
ribosome of Phillips and Rimler (94) , and a component isolated from a 
KSCN extract by us (107). The chemical nature of these LPS-protein 
complexes responsible for induction of immunogenicity in hosts has not 
been determined. However, recent studies on LPS-protein complexes 
extracted from other Gram-negative bacteria with trichloroacetic acid or 
butanol indicated that the protein moiety of the complexes may play an 
important role. The protein moiety, called endotoxin protein or lipid-A 
associated protein, exhibited several immunostimulatory activities such 
as induction of mitogenic response of B cells (46, 118), polyclonal 
activation of murine lymphocytes (119) , various stimulatory activities on 
macrophages and neutrophils (86) , and protection of mice against 
homologous bacterial infection (64). 
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Immune Responses to Pasteurella multocida Infection 
In cattle 
In addition to preexisting non-specific resistance and clearance 
mechanisms, Immunologically-specific resistance mechanians in the 
respiratory tract of various animal species are important in the control 
of various infectious agents associated with respiratory diseases (49, 
90, 122, 126, 127). However, respiratory immune responses of cattle to 
P. multocida infection have not been extensively studied. At present, 
limited information on the role of bovine immune system in protection 
against P. multocida infection is available from studies of the systemic 
immune system. As studies on evaluation of P. multocida bacterin 
indicated previously, there was no correlation between the increase of 
serum P. multocida antibody titer and protection of cattle (50, 70). 
Maheswaran and Thies (78) developed a whole blood lymphocyte stimulation 
assay to study cell-mediated immune responses of cattle to P. multocida 
infection. They observed that peripheral blood lymphocytes from cattle 
immunized with a pneumonic pasteurellosis strain (type A) exhibited 
higher stimulation indices when incubated with the antigens of the 
homologous strain than with the antigens of hemorrhagic septicemia 
strains (types B and E). These studies may suggest that honorai immunity 
is not as important as cellular immunity in cattle; however, the systemic 
immune response of cattle to P. multocida infection may not be the same 
as the local respiratory immune response. Studies on the respiratory 
immune system of many animal species have indicated that the respiratory 
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system is relatively ccxnpartmentalized from blood and blood-derived 
immune responses, particularly in the upper areas (49, 90, 122, 126). 
The respiratory systan itself is canpartmentalized immunologically into 
upper, middle and lower areas with apparent functional differences 
occurring in each area. Both humoral and cell-mediated immune responses 
occurred within the respiratory systan. 
In mice 
Collins and Vfoolcock at Trudeau Institute conducted extensive 
studies on the immune responses of mice to multocida infection. 
Collins (29) quantitated the growth of P. multocida in both normal mice 
and mice immunized with a P. multocida bacterin. In normal mice 
challenged intraperitoneally, the bacteria spread rapidly to the liver 
and spleen via the blood. Numbers of bacteria recovered from the blood, 
liver, spleen and peritoneal cavity were quantitated hourly up to 12 h 
and all rose continuously. In immunized mice, however, the bacteria were 
rapidly cleared from the blood and nimbers of bacteria in the liver, 
spleen and peritoneal cavity rose slightly by 6 h post challenge and then 
gradually decreased. Increased agglutination titers correlated with the 
degree of protection in the immunized mice. In addition, mice that 
received 0.2 ml of hyperimmune serum at 1 to 14 days prior to challenge 
were significantly protected against 100 to 1000 lethal challenge doses. 
Although both actively or passively immunized mice effectively limited 
the growth of bacteria in vivo, peritoneal cells from immunized mice did 
not exhibit increased bactericidal capacity in vitro as compared to the 
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cells from the control mice. 
Woolcock and Collins (130) further evaluated the immune mechanians 
in 2» multocida-infected mice. When the bacterin was incorporated into 
Freund's complete or incomplete adjuvants, protection with the 
incorporated bacterins was always superior to that seen with the non-
incorporated bacterin. Live Mycobacterium bovis, or killed 
Corynebacterium parvum immunopotentiated a single dose of the bacterin in 
terms of protective immunity against subsequent challenge. Hyper immune 
mouse serum, administered intraperitoneally, intramuscularly, or 
intravenously 1 to 7 days prior to subcutaneous challenge, was highly 
protective to mice. However, mice injected in the thigh with hyperimmune 
serum prior to footpad challenge frequently developed a severe 
inflammatory response with local swelling within 48 h. Although none of 
these mice died, many of their feet developed multiple abscesses 
exhibiting a predominantly polymorphonuclear leukocyte response, which 
persisted for at least 14 days. A purulent exudate could be expressed 
frcm these abscesses with bacterial counts of up to 10^  viable organisms. 
Injection of organisms recovered frcm the pus into normal mice revealed 
that the bacteria within the abscess were still fully mouse-virulent, 
indicating that the long-term survival of the serum-treated mouse was due 
to the acquired resistance induced by the local P. multocida infection 
and not to the attenuation of the organisms within the footpad. 
Collins and Woolcock (31) evaluated the roles of hyperimmune serum 
and peritoneal or spleen cells from the immunized mice in protection of 
mice against P. multocida infection. For evaluation of hyperimmune 
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serum, normal mice were injected intraperitoneally with P. multocida 
organisms suspended in 0.2 ml of heat-inactivated normal or hyperirtrnune 
mouse serum. After 2 min, mice were killed and the peritoneal cavity was 
washed with 2.5 ml of Hanks' balanced salt solution. The washouts were 
placed in small plastic tubes and incubated at 37 C in a shaking water 
bath. Viable counts of cell-associated and extracellular bacteria were 
carried out at frequent intervals over the next 60 rain by means of 
differential centrifugation. When the inoculum was suspended in normal 
serum, only 1 to 2% of the bacteria were taken up by the cells from the 
washout over a 60 min interval. Throughout this time, the extracellular 
bacterial population multiplied freely, resulting in a 100-fold increase. 
The proportion of the extracellular to cell-associated bacteria remained 
constant throughout the test period. On the other hand, mice receiving 
hyperimmune serum demonstrated a dramatic shift in the ratio of the 
extracellular to cell-associated bacteria present in the culture. 
Approximately 90 to 95% of the organisms were taken up by the cells fron 
the washout at 60 min. However, there was little evidence of increased 
bacterial inactivation over the period and, in fact, the P. multocida 
viable counts rose steadly at about the same rate whether immune serum 
was present in the system or not. For the active transfer study, mice 
were immunized with the bacterin and challenged. Seven days later the 
surviving mice were sacrificed to obtain peritoneal and spleen cells. 
Suspensions of 1 to 2 x 10® nucleated peritoneal or spleen cells, or a 
combination of the two were injected intravenously or intraperitoneally 
into the normal mice. However, these mice were not protected against 
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lethal effects of the P. multocida challenge. 
Based on these results in addition to other successful passive 
protection studies on multocida infection (5, 22, 65), Collins (30) 
concluded that immunity to multocida infection is primarily humorally-
mediated. Although the final clearance mechanise of P. multocida by the 
effectively-immunized host is not known, a role for anti-£. multocida 
antibody is suggested in the inhibition of the rapid spread of the 
organism to the blood stream and other reticuloendothelial organs. 
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SECTION I. ANALYSIS OF LIPOPOLYSACCHARIDES OF PASTEURELLA MULTOCIDA 
AND SEVERAL GRAM-NEGATIVE BACTERIA BY GAS CHROMATOGRAPHY 
ON A CAPILLARY COLUMN 
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SUMMARY 
Lipopolysaccharides (LPS) of Pasteurella multocida (P. multocida) 
and several other Gram-negative bacterial pathogens were analyzed by 
methanolysis, trifluoroacetylation and gas chromatography (GC) on a 
fused-silica capillary column. The GC analysis indicated that LPS 
prepared fran a strain of JP. multocida by phenol-water (PW) or 
trichloroacetic acid (TCA) extraction were quite different in chemical 
composition. However, LPS prepared from Salmonella enteritidis by the 
two extraction methods were very similar. PW-LPS extracts from different 
Pasteurella strains of a serotype had essentially identical GC patterns. 
Endotoxic LPS extracted from 16 different serotypes of P. multocida by PW 
or by phenol-chloroform-petroleum ether procedures yielded chromatograms 
indicating similar composition of the fatty acid moieties but minor 
differences in carbohydrate content. When the chemical composition of 
endotoxic LPS extracted from several Gram-negative bacteria (£. 
multocida, Pasteurella haemolytica, Haemophilus somnus, Actinobacillus 
ligniersii. Brucella abortus, Treponema hyodysenteriae, Escherichia coli, 
Bacteroides fragilis, Salmonella abortus equi and Salmonella enteritidis) 
were examined, each bacterial LPS showed a unique GC pattern. The 
carbohydrate constituents in LPS of various Gram-negative bacteria were 
quite variable not only in the 0-specific polysaccharide but also in the 
core polysaccharide. The LPS of closely related bacteria shared more 
fatty acid constituents with each other than with unrelated bacteria. 
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INTRODUCTION 
Pasteurella multocida (P. multocida) is a microorganism capable of 
infecting most animal species including man and is responsible for 
economically important animal diseases such as fowl cholera and pneumonic 
pasteurellosis in cattle (3, 4). The scientific and economic importance 
of P. multocida has led to the use of various bacterial fractions in the 
development of immunizing agents and for the study of bacterial 
pathogenicity. Studies on subcellular fractions of P. multocida have 
indicated that many fractions with demonstrated immunogenicity contained 
1ipopolysaccharide (LPS) as an important constituent (7, 8, 9, 19, 20, 
23) . 
The P. multocida LPS extracted by conventional methods (phenol-
water, phenol-chloroform-petroleum ether or trichloroacetic acid) has 
been observed to evoke a variety of endotoxic activities in a host 
including pyrogenicity, depression, diarrhea and death in mice, rabbits 
and chickens and lethality for chicken atibryos (1, 4, 18) . Since these 
endotoxic activities have also been demonstrated in LPS of many Gram-
negative bacteria, it has been generally believed that P. multocida LPS 
is structurally similar to other Gram-negative bacterial LPS (1, 21). 
However, the chemical relationships between LPS of P. multocida and other 
Gram-negative bacteria has not been studied extensively. In addition, 
the chemical relationships between the endotoxic LPS of P. multocida 
prepared by different methods-have not been studied. 
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Methods previously utilized for the chanical characterization of £. 
multocida LPS wer'e based on detection of fatty acids and colorimetric 
assays for 2-keto-3-deoxy-octonate (KDO), glucosamine, L-glycero-D-
mannoheptose (LD-heptose) and neutral sugars that are well-known 
components of Gram-negative bacterial LPS (especially Salmonella 
species). However, this chanical analysis requires several different 
assay systems that are time consuning. Also, the chemical composition of 
P. multocida LPS may be variant with composition of bacterial LPS in 
extensively studied microorganisms. The fatty acid content of bacterial 
LPS should be determined as well for it may be the carbohydrate content. 
This is indicated by the studies on synthetic Salmonella lipid A 
analogues which indicated that variant composition of fatty acids 
exhibited differences in biological activities such as antigenicity, 
lethality, pyrogenicity, mitogenicity and canplement activity (12). 
Recently, Bryn and Jantzen (3) dempnstrated that analysis of LPS by 
methanolysis, trifluoroacetylation and gas chromatography on a capillary 
column was a highly useful method for determining the chemical 
composition of bacterial LPS. The objectives of this study were: 1) to 
analyze the chemical composition of purified P. multocida LPS for future 
analysis of LPS-containing immunogens of the organism and 2) to examine 
chemical relationships between the endotoxic LPS of P. multocida prepared 
by different methods and from different serotypes, and the relationships 
between P. multocida LPS and LPS frcm other Gram-negative bacterial 
pathogens. 
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MATERIALS AND METHODS 
Cultivation of Bacteria 
P. multocida and Pasteurella haemolytica (P. haemolytica) were grown 
in Roux bottles containing dextrose starch agar (Difco Laboratories, 
Detroit, MI). Salmonella abortus equi (S. abortus equi) was grown in 
Roux bottles containing trypticase soy agar (Difco). Actinobacillus 
ligniersii (A. ligniersii) was grown in brain-heart infusion broth (BHI; 
Difco) with aeration. Haemophilus sotnnus (H. somnus) was grown in Roux 
bottles containing BHI, 5% agar (Difco) and 10% sterile bovine serum with 
5% COg aeration. After incubation at 37 C for 18 h, the Roux bottle-
grown bacteria were suspended in 0.15 M sterile phosphate buffered saline 
solution (PBS, pH 7.2). These bacteria and the broth-grown bacteria were 
harvested by centrifugation. Cells were washed three times with PBS by 
centrifugation and resuspended in distilled water. 
LPS Preparation by Phenol-Water Extraction 
Phenol-water extracted LPS (PVf-LPS) of £. multocida (strain P-2383 
and P-1062; capsular type A, somatic type 3), P. haemolytica D-80 
(biotype A, serotype 1), H. somnus 8025, A. ligniersii and S. abortus 
equi were prepared according to the method of Westphal and Jann (26) with 
slight modifications. Briefly, the bacterial suspension in distilled 
water was heated to 65 C and an equal volume of prewarmed (65 C) 90% 
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phenol was added. This mixture was stirred vigorously, incubated for 15 
min at 65 C and centrifuged at 3,000 x g at 4 C. The water phase was 
aspirated off, the original volume of distilled water was added to the 
remaining phenol phase, and the extraction repeated. The first and 
second water phases were combined and dialyzed against daily changes of 
distilled water for 4 days. The dialyzed water phase was treated with 
ribonuclease and deoxyribonuclease (Sigma Chanical Co., St. Louis, MO) 
for 24 h at 37 C and centrifuged at 105,000 x g for 3 h at 4 C. The 
pellet was washed once by centrifugation, resuspended in distilled water 
and lyophilized. 
LPS Preparation by Trichloroacetic Acid (TCA) Extraction 
TCA extracted LPS (TCA-LPS) of P. multocida (P-2383) was prepared 
according to the method of Staub (24) . Briefly, the washed bacteria were 
suspended in cold (4 C) distilled water and an equal volume of 0.5 N TCA 
was added. After incubation for 3 h at 4 C, the mixture was centrifuged 
at 3,000 X g for 30 min. The supernatant was removed, warmed to rocm 
temperature, neutralized to pH 6.5 with 3 N NaOH, cooled to 0 C in an ice 
bath, and added to 2 volumes of 100% ethanol (-20 C). The precipitate 
which formed following overnight incubation at -4 C was sedimented by 
centrifugation. The supernatant fluid was discarded and the precipitate 
was dissolved in distilled water to 0.1 the volume of the original 
bacterial suspension. Microbial debris was removed by centrifugation at 
27,000 X g and the supernatant fluid was lyophilized. 
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Other Bacterial LPS 
LPS from 16 somatic types of P. multocida prepared by either the PW 
procedure (26) or the phenol-chloroform-petroleum ether (PCP) procedure 
(6) were kindly provided by Dr. R. B. Rimler, National Animal Disease 
Center (NADC), U. S. Department of Agriculture (USDA), Ames, Iowa. A PW-
LPS preparation fron P. haemolytica P-101 (biotype A, serotype 1) was 
obtained from Dr. G. H. Frank, NADC, USDA. A Brucella abortus LPS f5 (B. 
abortus) was prepared by PW procedure with extraction from the phenol 
phase rather than the water phase as previously described (14) and was 
supplied by Dr. B. L. Deyoe, NADC, USDA. PW-LPS of Treponema 
hyodysenteriae (T. hyodysenteriae), Esherichia coli K235 (E. coli) and 
Bacterioides fragilis 9F (B. fragilis) were obtained from Dr. M. J. 
Wannemuehler, Veterinary Medical Research Institute, Iowa State 
University, Ames, lA. TCA-LPS and PW-LPS of Salmonella enteritidis (S. 
enteritidis) were purchased from Sigma Chanical Co. 
Standards 
Various individual standards vere used for determination of the 
retention times as well as internal standards in GC analysis. Rhainnose, 
fucose, ribose, galactose, mannose, glucose, glucosamine and KDO were 
obtained frcxn Sigma. D-glycero-D-mannoheptose (DD-heptose) and L-
glycero-D-mannoheptose (LD-heptose) v^ re provided by Dr. P. A. Rebers, 
NADC, USDA. Unhydroxylated fatty acids from carbon chains 12 to 17 were 
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obtained fron Applied Science (State College, PA) and 3-hydroxy-
dodecanoate (3-0H-12:0), 2-hydroxy-tetradecanoate (2-0H-14;0) and 3-
hydroxy-tetradecanoate (3-0H-14;0) were purchased from Foxboro/Analabs 
(North Haven, Conn). A bacterial fatty acid mixture (Cat. No. 4-7080) 
was purchased from Supelco (Bellefonte, PA). 
Preparation of Samples 
Derivatization of the LPS was performed by the method of Bryn and 
Jantzen (3) with slight modifications. Briefly, 2 to 5 mg of bacterial 
LPS were suspended in one ml of 2 M HCl in methanol (Supelco) in a 
teflon-lined screw-capped vial (Supelco) and held at 85 C for 18 h. 
Methanolysates were concentrated to dryness at room temperature with 
nitrogen gas and trifluoroacetylated by adding 0.2 ml of 50% 
trifluoroacetic acid (TFA, gold label; Aldrich Chemical Inc., Milwaukee, 
WI) in acetonitrile (HPLC grade; Fisher Scientific, Fair Lawn, NJ) and 
heating in a boiling water bath for 2 min. After cooling to room 
temperature, the reaction mixture was diluted with acetonitrile to a 
final TFA concentration of 10% and injected into the column. 
Gas Chromatography (GC) and Peak Identification 
The GC analysis was carried out on Hewlett-Packard 402 gas 
chromatography systan equipped with a flame-ionizing detector that had 
been modified for the use of a capillary column. Fused-silica capillary 
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columns (GB-1, 25 m x 0.25 mm ID, Foxboro/Analabs, or SPB-1, 30 m x 0.25 
ram ID, Supelco) were operated in split mode and with helium carrier gas. 
The column tanperature was held for 5 min at 95 C and then programmed to 
increase at 4 C per min up to 230 C. Peaks of individual standards and 
bacterial LPS were recorded with a LKB 2210 recorder (Brarma, Sweden) and 
retention times were calculated by the distance the individual peak moved 
from the injection line on the chroma tog ram. Sdrrroe the LKB recorder was 
not equipped with an internal integrator, the quantity of individual 
constituents could not be determined. 
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RESULTS 
Determination of Retention Times of Standard Compounds 
As indicated by Bryn and Jantzen (3), most monosaccharide 
derivatives are resolved into defined peaks by a capillary column. The 
specific GC patterns of standard compounds in this experimentation were 
very similar to those reported by Bryn and Jantzen (3). However, it was 
necessary to separate the components of LPS with splitter open in 
contrast to the procedure of Bryn and Jantzen which was conducted in 
splitless mode. Also, they observed the third galactose peak between the 
second glucose peak and the second mannose peak, but in our study, it 
appeared at the same position as the first glucose peak. Retention times 
of the individual standard compounds on the GB-1 column are listed in 
Tables 1 and 2: the SPB-1 column gave slightly different retention times, 
but the chromatographic sequence was the same as the GB-1 column. 
Chanical Composition of P. multocida LPS 
Since LPS extracted from enterobacteria is a classical example of 
bacterial endotoxin, LPS prepared from S. enteritidis was utilized as a 
standard for comparison with LPS preparations of P. multocida and other 
bacteria. In contrast to LPS preparations from S. enteritidis (Fig. 1), 
LPS prepared from a JP. multocida strain by TCA or PW extraction was quite 
different in chemical composition (Fig. 2). The PW-LPS of P. multocida 
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Table 1. Gas chromatographic distribution of some commonly occurring LPS 
monosaccharides as trifluoroacetylated methylglycosides on a 
fused-silica capillary column (GB-1) 
Conponent Retention times (min) 
Rhamnose 6.1 7.35 
Fucose 6.35 6.75 7.8 
Ribose 4.9 6.15 6.4 
Galactose 10.3 11.15 11.85 
Mannose 11.6 12.45 
Glucose 11.85 12.0 
D-glycero-D-mannoheptose 15.0 
L-glycero-D-mannoheptose 15.8 
Glucosamine 17.35 
2-keto-3-deoxy-octonate 19.85 20.65 
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Table 2. Retention times of common LPS fatty acids as (0-
trifluoroacetylated) methyl esters on a fused-silica capillary 
column (GB-1) 
Retention time (min) 
Chain length Unhydroxylated 2-Hydroxy 3-Hydroxy 
C-12 19.25 - 21.95 
C-13 22.45 
C-14 25.35 27.05 27.45 
C-15 28.2 
C-16 30.8 
C-17 33.4 
FIG. 1. Gas chromatograms from a SPB-1 column of two enteritidis LPS 
preparations by TCA and PW extractions after methanolysis and 
trifluoroacetylation. Conditions of sample preparation and 
chromatography are given in the text. Abbreviations: Tyv, 
tyverose; Abq, abequose; Rha, rhamnose; Gal, galactose; Man, 
mannose; Glc, glucose, DD-Hep, E)-glycero-D-mannoheptose; LD-Hep, 
Ei-glycero-D-raannoheptose; GlcN, glucosamine; KDO, 2-keto-3-
deoxy-octonate; 12:0, dodecanoate; 3-OH-12:0, 3-hydroxy-
dodecanoate; 14:0, tetradecanoate; 2-OH-14:0, 2-hydroxy-
tetradecanoate; 3-OH-14:0, 3-hydroxy-tetradecanoate; 16:0, 
hexadecanoate; i-16:0, 14-methyl-pentadecenoate; 3-OH-16:0, 3-
hydroxy-hexadecenoate; 17:0, heptadecanoate; 18:0, 
octadecanoate; 18:1^ , cis-9-octadecenoate 
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Pasteurella muttoclda, strain P-2383 (A,3) 
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FIG. 2. Gas chronatograms from a fused-silica capillary column (SPB-1) 
of P. multocida LPS prepared by TCA and PW extractions 
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contained many constituents characteristic of other Gram-negative 
bacterial LPS including LD-heptose, glucosamine, KDO, tetradecanoate and 
3-hydroxy-tetradecanoate. However, TCA-LPS of the organism appeared to 
contain more glucose and certain longer chain fatty acids that were 
absent in the PW-LPS. LPS extracted from 16 different serotypes 
exhibited similar chemical composition with identical fatty acid 
constituents regardless of the extraction methods. The differences were 
found that LPS extracted from encapsulated P. multocida (serotypes 3, 9 
and 13) by the PW procedure contained more polysaccharides than the LPS 
extracted from non-encapsulated serotypes by the PCP procedure. Also, 
minor variation were found in individual cabohydrate constituents. LPS 
of all serotypes contained glucose, galactose, LD-heptose, glucosamine 
and KDO. However, sane serotypes contained an additional constituent. 
For example, LPS of serotype 2 and 5 contained DD-heptose, but this 
compound was not detectable in LPS of other serotypes. In this respect, 
LPS from serotypes 2 and 5 appeared to be similar in chonical composition 
to P. haemolytica LPS (Fig. 3). However, P. haemolytica LPS contained a 
large quantity of dodecanoate which was either not detectable or present 
in limited quantity in P. multocida LPS. The PW-LPS from different 
strains of a conmon serotype of P. multocida (A, 3; P-1059, P-1062 and P-
2383) gave identical GC patterns. The same was true for P. haemolytica 
(A, 1; P-101 and D-80). 
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FIG. 3. Gas chromatograms from a fused-silica capillary column (GB-1) of 
LPS preparations from Pasteurella species 
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Chonical Relationship of PW-LPS between P. multocida and Other 
Gram-Negative Bacteria 
The PW-LPS of Gram-negative bacteria closely related to £. multocida 
possessed a chemical composition similar to that of multocida (Fig. 
4). The LPS of A. ligniersii, a species of the genus Actinobacillus 
within the family Pasteurellaceae, contained the same chemical 
constituents as multocida LPS with limited quantitative variations in 
glucose and galactose. The LPS of H. somnus, a species of uncertain 
affiliation within the genus Haemophilus in the family Pasteurellaceae, 
also had similar constituents, but it contained a larger quantity of KDO 
than other bacteria within the family. When LPS of bacteria with a 
lesser relationship with P. multocida were examined (Figs. 1, 5, 6), 
compositional variations were found in both the carbohydrate and fatty 
acid moieties. However, the LPS of enteric bacteria (Salmonella species 
and coli) did share several typical LPS constituents with £. multocida 
LPS such as LD-heptose, KDO and 3-hydroxy-tetradecanoate (Figs. 1, 5, 6). 
The LPS of B. abortus also contained 3-hydroxy-tetradecanoate (Fig. 5), 
but absence of LD-heptose and predominance of long chain fatty acids made 
it uniquely different from other bacterial LPS. The LPS of T. 
hyodysenteriae and B. fragilis contained completely distinctive fatty 
acid moiety as conpared to LPS of Salmonella species, E. coli and genera 
of the family Pasteurellaceae (Fig. 6). LPS of both bacteria contained 
13-hydroxy-methyl-tetradecanoate and 3-hydroxy-hexadecanoate as main 
fatty acid constituents rather than tetradecanoate and 3-hydroxy-
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FIG. 4. Gas chromatograms frcm a fused-silica capillary column (GB-1) of 
LPS preparations from H. somnus and A. ligniersii 
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FIG. 5. Gas chranatograms from a fused-silica capillary column (GB-1) of 
LPS preparation from abortus equi and B. abortus (f5) 
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B. fragilis (9F) 
54 
tetradecanoate (27). B. fragilis LPS contained additional fatty acids 
such as 3-hydroxy-pentadecanoate, 3-hidroxy-15-methyl-hexadecanoate and 
3-hydroxy-heptadecanoate. 
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DISCUSSION 
Bacterial LPS is a chemically heterogeneous material which is 
present in the outer msnbrane of Gram-negative bacteria and has a variety 
of biological activities in a host; these activities may include 
toxicity, metabolic alterations or immunological effects (10, 11, 13, 
25). LPS isolated fran Salmonella species has been characterized most 
extensively and structurally these LPS are composed of three chemically 
distinctive regions including 0-specific polysaccharide, core 
polysaccharide and lipid A region (10, 11, 13, 25). Common components of 
the Salmonella LPS are LD-heptose, KDO and 3-hydroxy-tetradecanoate. 
For many years, it was thought that the LPS contains a molecular 
component common to all Gram-negative bacteria. Variation in the 
structure resided in the polysaccharide moiety, while the remainder of 
the structure is the same in all LPS molecules regardless of origins. 
Earlier chemical studies on LPS of the family Enterobacteriaceae by 
Luderitz and coworkers seemed to support this premise (11, 13); recently, 
Nowotny and his colleagues questioned the validity of this assumption 
based on their experimental evidence (15, 16). They found obvious 
differences in the chemical composition, particularly in fatty acid 
constituents, of LPS prepared from a bacterium by different methods and 
between LPS from different bacterial species. 
The results in this study on chemical analysis of JP. multocida and 
several Gram-negative bacterial LPS by GC clearly danonstrated the 
compositional heterogeneity of various LPS preparations in support of the 
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findings of Nowotny and his colleagues (15, 16). Compositional 
differences between LPS extracted by PW and TCA procedures from a P. 
multocida organisa (Fig. 2) indicated that extraction methods influenced 
the chsnical character of LPS. This contrasted with enterobacterial LPS 
which seemed to be similar in chemical composition irrespective of the 
methods utilized for extraction (Fig. 1). An interesting observation is 
the finding that the PCP extraction of the non-encapsulated serotypes of 
P. multocida yielded LPS similar to the PW-LPS from the encapsulated 
serotypes. This observation may indicate that P. multocida LPS is 
basically similar in chemical composition irrespective of the serotype. 
The PCP method has been used for extraction of LPS fron non-encapsulated 
bacteria since LPS fron these bacteria is more soluble in PCP than in 
water (6). This is apparently due to the lack of 0-specific 
polysaccharide in non-encapsulated bacteria. This increases 
hydrophobicity of LPS of non-encapsulated bacteria as compared with LPS 
from encapsulated bacteria. The reason v^ y different extraction methods, 
PW and TCA procedures, influenced the chemical character of LPS from an 
encapsulated £. multocida is difficult to explain. However, this 
difference may result from the surface character of the encapsulated 
organism, particularly the mucoid nature of the capsule. The capsule may 
influence the effectiveness of TCA in dissociating LPS from the mucoid 
organism. 
The O-specific polysaccharide is reported to exhibit serotype 
specificity of individual bacteria and to be extremly heterogeneous in 
chemical composition (10, 11, 13, 15, 25). Studies on Salmonella LPS 
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indicated that the repeating unit of oligosaccharide in the O-specific 
polysaccharide is the most important factor for determination of serotype 
specificity; individual somatic polysaccharides may exhibit several 
serologic specificities (11, 13/ 15). Observations in this study 
indicated that the carbohydrate constituents of P. multocida LPS were 
very similar between the different serotypes although quantity of the 
individual constituents was variable and some serotypes contained an 
additional sugar such as DD-heptose. Brogden and Rebers (2) reported 
chat LPS isolated from 16 different serotypes of P. multocida did not 
crossreact except for LPS of serotypes 2 and 5. Rimler et al. (21) 
quantitated carbohydrate composition of £. multocida LPS and found that 
LPS of serotypes 2 and 5 were markedly alike in chemical composition; 
both contained similar amounts of glucose, galactose, DD-heptose, LD-
heptose and KDO. However, LPS of serotype 1 that was also quite similar 
in chemical composition with LPS of serotypes 2 and 5, except for the ' 
lack of DD-heptose, did not crossreact with LPS of the two serotypes. 
This indicates that, in general, LPS of P. multocida contains an 0-
specific polysaccharide unique to the individual serotype and exhibits 
primarily one serologic specificity. This contrasts with findings on 
Salmonella LPS in which somatic polysaccharides may exhibit several 
serologic specificities (11, 13, 15). 
In contrast to the 0-specific polysaccharide, the constituents (LD-
heptose and KDO) of the core polysaccharide have been reported to be 
common to many Gram-negative bacteria, certainly to all in the family 
Enterobacteriaceae (10, 13). However, the results of this study 
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indicated that these conpounds were either absent or present in limited 
quantities in some bacterial LPS such as B. abortus and B. fragilis 
(Figs. 5, 6). Also, the apparent quantity of these compounds is quite 
variable in individual LPS from unrelated bacteria and even related 
bacteria within the facultative anaerobic Gram-negative bacteria that 
comprise the families Enterobacteriaceae and Pasteurellaceae (Figs. 1, 2, 
3, 4 , 6). For example, LPS of salmonella, shigella and escherichia may 
contain similar amounts of KDO as previously reported (11, 13); however, 
LPS of P. multocida, P. haemolytica and A. ligniersii from the family 
Pasteurellaceae contained a lesser quantity of KDO than LPS of H. somnus 
from the same family and the family Enterobacteriaceae (Figs. 3, 4). 
The fatty acid moiety of LPS, called lipid A, is known to represent 
the component of LPS which is responsible for its endotoxic properties 
(10, 11, 13, 15, 25). However, compositional differences in lipid A of 
various LPS preparations have been reported (12, 15, 16). The results of 
this study confirmed the heterogeneity in fatty acid components of 
various LPS preparations. Also, the results indicated that LPS of 
members of the family Pasteurellaceae (Figs. 3, 4) contained almost 
identical fatty acid constituents while they were slightly different from 
the LPS of enteric bacteria (Figs. 1, 5, 6) . Distinctive differences 
were noted in the fatty acid composition of LPS from unrelated bacteria 
(Figs. 5, 6). This indicates that the similarities and differences in 
the fatty acid composition of various Gram-negative bacterial LPS may 
depend on relationships between the bacteria. Differences in the 
relative endotoxicity of these bacterial LPS can be expected since 
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compositional differences in lipid A of different origin and in synthetic 
lipid A analogues have been demonstrated to influence biological 
activities of LPS including endotoxicity (12, 15, 16). 
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SECTION II. CHARACTERIZATION OF A LIPOPOLYSACCHARIDE-PROTEIN COMPLEX OF 
TYPE A PASTEURELLA MULTOCIDA 
64 
SUMI-IARY 
A lipopolysaccharide (LPS)-protein conplex isolated from a potassium 
thiocyanate extract of a Pasteurella multocida (P. multocida; strain P-
2383, capsular type A and sonatic type 3) was characterized. Chemical 
analysis of the complex by gas chromatography on a capillary column 
demonstrated that this complex contained most of the chemical 
constituents characteristic of LPS extracted by the phenol-water method 
from the whole bacterium. However, there apparently was more 
carbohydrate than fatty acid in the complex in contrast to LPS in which 
fatty acid seemed to be in excess. VJhen toxicity of the complex was 
evaluated in 10-day-old chicken embryos, the complex was less toxic (LDg^  
= 12.72 ug) than the purified LPS (LD^ q = 0.44 ug) . The LD^ q of the LPS 
moiety extracted from the complex was 5.24 ug. Composition of the 
complex was analyzed by SDS-PAGE with silver staining and Vfestern 
immunoblot. The complex did not migrate through the polyacrylamide gel 
unless dissociated with SDS. The complex dissociated with SDS contained 
more than 32 different protein and polysaccharide components; at least 18 
components reacted with an antiserum against the complex. There was no 
significant compositional variation between the complexes from different 
strains, but quantitative differences in individual components were 
noted. When cross-protectivity of the complex was evaluated in mice, 
this complex provided substantial protection not only against the 
homologous bacterium but also against different P. multocida strains of 
the same serotype. LPS-protein complexes isolated by the same method 
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from other strains also induced protection against a challenge with P-
2383. 
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INTRODUCTION 
Capsular type A and somatic type 3 strains of Pasteurella multocida 
(P. multocida) are known to be a major etiological factor of pneumonic 
pasteurellosis of cattle (3, 5, 6) and the economic loss to the U.S. 
cattle industry from the disease exceeds a half billion dollars annually 
(17). The importance of the organism has led to the use of various 
bacterins for prevention; however, immunization of cattle with 
Pasteurella bacterins has been demonstrated to be detrimental to the 
health of the animals in addition to questionable efficacy (9, 10, 15, 
21). Therefore, subcellular fractions of the bacterium have been studied 
extensively to find an effective immunizing agent. 
Lipopolysaccharides (LPS) present in the outer manbrane of Gram-
negative bacteria are known to play important roles in bacterial 
pathogenesis since they exhibit many endotoxic activities in a host such 
as pyrogenicity, depression, diarrhea, lethality for chicken anbryos, and 
death in mice, rabbits and chickens (13, 16, 18, 19, 33). LPS of P. 
multocida has also been reported to evoke such endotoxic activities (1, 
23, 25). Also, many researchers have suggested that the P. multocida 
fractions which possessed itnnunogenicity contained LPS as an important 
constituent (8, 11, 12, 22, 25, 26, 30). 
The presence of LPS in the immunogenic fractions of £. multocida has 
been determined by serologic cross-reactivity of the fractions with the 
purified LPS (11, 22, 25, 30), endotoxic activities in experimental 
animals and chicken embryos (8, 11, 12, 25, 26), or detection of 2-keto-
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3-hydroxy-octonate (KDO) and/or fatty acids by chsnical methods (8/ 12, 
22, 26). While these determinations may have suggested the presence of 
LPS, they failed to relate basic chemical differences between the 
immunogenic fractions and the purified LPS. 
Previously, we have reported the isolation of an immunogenic 
fraction fron a potassium thiocyanate (KSCN) extract of P. multocida 
(strain P-2383; capsular type A and somatic type 3) by sucrose-density 
gradient centrifugation (30). This fraction, called P-2383-1, was highly 
intnunogenic in mice and contained 27% protein and 12% carbohydrate. 
Although the fraction crossreacted serologically with LPS extracted from 
the whole bacterium by Vfestphal's phenol-water procedure, KDO was not 
detected in P-2383-1 at a protein concentration of 5 mg/ml. The 
objectives of this study were to determine the endotoxic LPS content in 
P-2383-1 and one other LPS-containing immunogen of multocida by gas 
chromatography on a fused-capillary column, to evaluate P-2383-1 for its 
toxic activity in chicken embryos, and to discern immunologic 
relationships between the LPS-protein complexes from different strains of 
the serotype by compositional analysis in sodinn dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and Western immunoblot. 
68 
MATERIALS AND METHODS 
Organism 
Five P. multocida strains (P-2383, E^ 9238, P-9663, P-9954, P-10027; 
capsular type A and somatic type 3) were used in this experimentation. 
Culture conditions for growth of P. multocida organisms, preparation of 
KSCN extracts and isolation of a LPS-protein complex, P-2383-1, fron a 
KSCN extract have been described previously (30). 
Isolation of LPS-Protein Complexes 
An immunogenic LPS-protein complex, called P-2383-1, was isolated 
from a KSCN extract of an encapsulated P. multocida (P-2383; capsular 
type A and somatic type 3) by sucrose-density gradient centrifugation 
(30). LPS-protein complexes, eqivalent to P-2383-1, isolated from 
different strains of the serotype were prepared by the same method and 
named P-9238-1, P-9663-1, P-9954-1 and P-10027-1. Another immunogenic 
LPS-protein complex, called P-1059-40p, was isolated from a 0.85% NaCl 
extract of a non-encapsulated variant (P-1059; capsular type A and 
somatic type 3) by gel-filtration as described by Ganfield et al. (8) and 
was kindly provided by Dr. R. B. Rimler, National Animal Disease Center 
(NADC), the United States Department of Agriculture (USDA), Ames, lA. 
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Fractionation of a LPS-Protein Complex 
P-2383-1 was fractionated into LPS and protein moieties by an 
extended %stphal's phenol-water procedure described by Sultzer and 
Goodman (34). Briefly, P-2383-1 dissolved in 0.32 M NaCl/0.01 M Tris-HCl 
buffer was dialyzed against distilled water at 4 C for 2 days and warmed 
to 65 C before treatment with equal volume of 90% phenol (65 C). The LPS 
moiety (P-2383-1-LPS) was isolated from the water phase while the protein 
moiety (P-2383-1-PRO) was collected from the phenol phase by 
precipitation with cold ethanol (-20 C). Since P-2383-1-PRO was poorly 
soluble in water, it was solubilized by suspending 2 mg (dry weight) in 
0.95 ml of distilled water and adding 0.05 ml of 0.1 N NaOH. 
Preparation of P. multocida LPS 
The phenol-water extracted LPS (PW-LPS) was prepared from strain P-
2383 by the method of Westphal and Jann (36) with slight modifications as 
described previously (30). 
Chemical Analysis 
Bacterial fractions were assayed for basic chemical content. Total 
carbohydrate was determined by the phenol-sulfuric acid procedure (7) 
using glucose (Sigma Chemical Co., St. Louis, MO) as a standard. Protein 
content was determined colorimetrically from the reaction of protein with 
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Serva blue G dye (Serva Fine Chemicals Inc., Long Island, NY) using 
bovine serum albumin (Sigma) as a standard (24). 
Gas Chromatography (GC) 
Derivatization of samples for GC analysis was performed by the 
method of Bryn and Jantzen (4) with slight modifications. Briefly, 2 to 
5 mg of the sample was suspended in one ml of 2 M HCl (Supelco, 
Bellefonte, PA) in a teflon-lined screw-capped vial (Supelco) and held at 
85 C for 18 h. The methanolysate was concentrated to dryness at rocm 
temperature with nitrogen gas and trifluoroacetylated by adding 0.2 ml of 
50% trifluoroacetic acid (TFA, gold label; Aldrich Chemical Inc., 
Milwaukee, WI) in acetonitrile (HPLC grade; Fisher Scientific, Fair Lawn, 
NJ) and heating in a boiling water bath for 2 min. After cooling to roan 
temperature, the reaction mixture was diluted with acetonitrile (HPLC 
grade; Fisher Scientific, Fair Lawn, NJ) to a final TFA concentration of 
10% and injected into the column. Galactose, glucose and KDO were 
purchased from Sigma chemical Co., and LD-heptose was kindly provided by 
Dr. P. A. Rebers, NADC, USDA, Ames, lA. These sugars were used for 
carbohydrate standards and a bacterial fatty acid mixture (Supelco) was 
used as a fatty acid standard. The GC analysis was carried out on 
Hewlett-Pachard 402 GC system equipped with a flame-ionizing detector 
that had been modified for the use of a capillary column. A fused-silica 
capillary column (GB-1, 25 m x 0.25 mm ID, Foxboro/Analabs, North Haven, 
Conn) was operated in a split mode and with helium carrier gas. The 
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column tanperature was held for 5 min at 95 C and then programmed to 
increase at 4 C per min up to 230 C. 
Production of Rabbit Antiserum 
Procedures for production of rabbit antiserum to Pasteurella 
fractions have been described previously (30) . White New Zealand female 
rabbits were used for immunization with P-2383-1. The antiserums 
obtained fron these rabbits produced a single precipitation line in 
crossed-inununoelectrophoresis with the immunizing antigen and 2 
precipitation lines were observed in the reaction with whole KSŒ 
extract. 
Chicken Eïnbryo Lethality 
The chicken enbryo lethality test was conducted by the method of 
Smith and Thomas (31). Groups of five 10-day-old embryonated eggs were 
inoculated with 0.1 ml volumes of 2-fold dilutions of the £. multocida 
fractions on the chorioallantoic membrane. The eggs were incubated at 37 
C and candled for viability at 24 and 48 h. Fifty percent of lethal dose 
(LD50) of the fractions was determined by the method of Reed and Muench 
(28) .  
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SDS-PAGE 
Discontinuous SDS-PAGE was performed with 10% separating gel and 5% 
stacking gel by the method of Laemmli (14) with slight modifications. 
Both separating and stacking gels were prepared from a 30% acrylaraide 
(Bio-Rad Laboratories, Richnond, CA) stock solution containing 0.8% N,N'-
methylene bis acrylamide (Bio-Rad). The separating gel (100 ml) 
contained 33.3 ml of the stock solution, 20 ml of 1.5 M Tris-HCl (Sigma), 
pH 8.9, 1 ml of 10% SDS, 20 ml of 50% sucrose solution and 25.7 ml of 
distilled water. Five ul of TEMED (N,N,N',N'-tetramethylethylenediamine, 
Bio-Rad) and 8 ul of freshly prepared 10% ammoniim persulfate (Bio-Rad) 
were added to 10 ml of the degassed separating gel. The stacking gel 
(100 ml) contained 16.8 ml of the stock solution, 12.5 ml of 0.5 M Tris-
HCl, pH 6.8, 1 ml of 10% SDS, and 69.7 ml of distilled water. Five ul of 
TEMED and 0.1 ml of 10% ammoniim persulfate were added to 10 ml of the 
degased stacking gel. Sample preparation buffer (100 ml) contained 2 g 
of SDS, 10 ml of glycerol, 10 ml of 0.04% bromophenol blue, 12.5 ml of 
0.5 M tris-HCl, pH 6.8 and 67.5 ml of distilled water. Prior to use for 
treatment of sample, 0.1 ml of 2-mercaptoethanol was added to 10 ml of 
the buffer. One-tenth ml of this solution was added to the same volume 
of an individual sample and the mixture was heated for 4 min in a boiling 
water bath (95 C). One-tenth mg of proteinase K (PK, Sigma) solubilized 
in 10 ul of the sample preparation buffer was added to the sample mixture 
subject to protein digestion and incubated for 1 h at 60 C. Samples were 
loaded onto the polyacrylamide gels in a volume of 20 to 30 ul and 
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separated for 6 to 7 h at 25 mA per gel (16 an x 11.5 cm x 0.15 an). 
After the electrophoresis, the gel was fixed overnight in 25% (vol/vol) 
2-propanol-10% (vol/vol) acetic acid solution. Silver staining was 
conducted with a silver staining kit (Accurate Chemical & Scientific 
Corp., Westbury, NY) according to the recommended procedure. 
Western Immunoblot 
Western immunoblot was performed according to the method of Towbin 
et al. (35) . The polyacrylamide gel subject to immunoblot was washed for 
1 h in a blotting buffer solution containing 25 mM Tris-HCl, 192 mM 
glycine and 20% (vol/vol) methanol (pH 8.3). Separated components in the 
gel were electroblotted to a nitrocellulose manbrane (Bio-Rad) for 5 h at 
21 mA. The membrane was incubated overnight in a Tris-buffered saline 
solution (TBS; 20mM Tris-HCl, 0.5 M NaCl, pH 7.5) containing 3% bovine 
serum albumin. The membrane was washed 3 times in TBS containing 0.0005% 
(vol/vol) of Tween 20 (TTBS). Rabbit antiserum against P-2383-1 was 
diluted to 1:100 in TTBS containing 1% gelatin. The membrane was 
incubated overnight in this antibody solution. The membrane was washed 3 
times with TTBS and incubated for 1 h in a TTBS-1% gelation solution 
containing 1:500 peroxidase-labeled goat anti-rabbit IgG (Sigma). The 
manbrane was washed twice with TTBS and once with TBS, and incubated in 
TBS containing 60 mg HRP color development reagent (Bio-Rad), 20 ml of 
methanol, 60 ul of 20% (vol/vol) hydrogen peroxide. 
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Mouse Immunization and Challenge 
White Swiss mice of one sex, 8 weeks of age, and at least 18 g in 
weight (Bio-Lab Corp., St. Paul, MN) were utilized for this study. All 
mice were immunized subcutaneously with 0.1 ml (1 mg/ml protein 
concentration) of antigen and challenged intraperitoneally 2 weeks later 
with 0.1 ml of bacterial suspension (100 to 200 CFU). Mice were observed 
for 1 week after the challenge and deaths recorded. 
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RESULTS 
GC Analysis 
GC analysis indicated that the constituents of PW-LPS of P. 
multocida were galactose, glucose, LD-heptose, glucosamine, KDO, 3-
hydroxy-dodecanoate, tetradecanoate, 3-hydroxy-tetradecanoate and 
hexadecanoate (Fig. 1). As illustrated in Fig. 2, both LPS-containing 
immunogens, P-1059-40p and P-2383-1, contained most of the chanical 
constituents present in PW-LPS of P. multocida except that KDO was 
difficult to detect in P-2383-1. However, the differences were observed 
in GC patterns of the three preparations indicating quantitative 
variations within the shared constituents. P-2383-1 contained a higher 
ratio of carbohydrate to fatty acid than P-1059-40p and PW-LPS. The 
immunogenic fractions contained considerable amounts of long chain fatty 
acids such as hexadecanoate that were present in limited quantity in PtJ-
LPS. 
Chanical Analysis 
The LPS-protein complexes of several P. multocida strains, 
equivalent to P-2383-1, contained 5 to 27% carbohydrate and 22 to 38% 
protein. The LPS moiety of P-2383-1 contained 50% carbohydrate and PW-
LPS contained 24% carbohydrate. 
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Lv ->L 
Pasteurella multocida, strain P-2383 (A,3) 
LPS from phenol-water extraction 
LO-Hep 
QlcN 
KDO 
35 
215 
25 
175 
15 
135 
5 
95 
min 
1. Gas chromatogram of the phenol-water extracted LPS of P. 
multocida (strain P-2383) after methanolysis and 
trifluoroacetylation. Conditions of sample prepartion and 
chromatography are given in the text. Abbreviations: Gal, 
galactose; Glc, glucose; LD-Hep, L-glycero-D-mannoheptose; GlcN, 
glucosamine; KDO, 2-keto-3-hydroxy-octonate; 3-0H-12:0, 3-
hydroxy-dodecanoate; 14:0, tetradecanoate; 3-OH-14:0, 3-hydroxy-
•tetradecanoate; 16:0, hexadecanoate 
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FIG. 2. Gas chronatograns of LPS-containing immunogens of P. multocida. 
Abbreviations are listed in the legend of Fig. 1 
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Chicken Embryo Lethality 
Results of toxicity assays for P-2383-1, its LPS moiety (P-2383-1-
LPS) and PW-LPS in 10-day old chicken embryos are listed at Table 1. The 
PW-LPS exhibited the highest toxicity with a LD^ Q of 0.44 ug while P-
2383-1 exhibited the lowest toxicity with a LD^Q of 12.72 ug. The LD^Q 
of the LPS moiety extracted from P-2383-1 was 5.24 ug. 
Compositional Analysis of the LPS-Protein Complexes 
The LPS-protein complexes which were not treated with SDS did not 
migrate through the polyacrylamide gel. The complexes treated with SDS 
showed visible bands in the polyacrylamide gel at a 0.5 mg/ml protein 
concentration; however, the protein moiety of P-2383-1 required at least 
4 mg/ml protein concentration to show visible bands. The LPS-protein 
complexes contained at least 32 protein and polysaccharide components 
with the molecular size ranging from less than 14.3 kilodaltons to 
greater than 94 kilodaltons (Fig. 3). Most of these components were 
protein in nature since they were destroyed by proteinase K treatment 
(Fig. 4). At least 4 polysaccharide bands of different molecular sizes 
were identified; however, the predominant band was of smaller molecular 
size (Fig. 4). Most of these components were shared between the 
complexes isolated from different strains, but the quantity of individual 
components was somewhat variable. Analysis by Western immunoblot (Fig. 
5) indicated that at least 18 of those components reacted with an 
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Table 1. Lethality for chicken embryos of fractions extracted frcm £. 
multocida 
Dosage (ug) PW-LPS P-2383-1 P-2383-1-LPS 
64 - 6/6^  -
32 - 4/6 -
16 - 4/6 6/6 
8 - 3/6 5/6 
4 6/6 0/6 2/6 
2 6/6 0/6 1/6 
1 5/6 - 0/6 
0.5 4/6 - -
0.25 1/6 - -
0.125 0/6 - -
o^. of dead/no. tested. 
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FIG. 3. SDS-PAGE profiles of LPS-protein complexes isolated fron P. 
multocida strains of capsular type A and sonatic type 3 as 
revealed by silver staining. The lanes and fractions were as 
follows: 1, molecular weight standard; 2, P-2383-1; 3, P-9238-1 
4, P-9663-1; 5, P-9954-1; 6, P-10027-1 
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FIG. 4. SDS-PAGE profiles of the fractions of P. multocida as revealed 
by silver staining. The lanes and fractions were as follows: 1, 
PW-LPS; 2, P-2383-1-LPS + PK; 3, P-2383-1-PRO + PK; 4, P-2383-1-
LPS; 5, P-2383-1-PRO; 6, P-2383-1 + PK; 1, P-2383-1; 8, P-9238-
1; 9, P-9663-1; 10, P-9954-1; 11, P-10027-1; 12, molecular 
weight standard 
82 
=v4-. 
( > 
I Vi 
•'•hvii ~ 
it:;o 
K 
2 3 4 5 6 7 8 9 10 11 
FIG. 5. Western iiraiunoblot of the fractions of P. multocida stained by 
peroxidase-labeled goat anti-rabbit IgG. The lanes and 
fractions were as follows; 1, PW-LPS; 2, P-2383-1-LPS + PK; 3, 
P-2383-1-PRO + PK; 4, P-2383-1-LPS; 5, P-2383-1-PRO; 6, P-2383-1 
+ PK; 7, P-2383-1; 8, P-9238-1; 9, P-9663-1; 10, P-9954-1; 11, 
P-10027-1 
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antiserum against P-2383-1. 
Immunogenicity in Mice 
As indicated at Table 2, groups of mice immunized with the LPS-
protein complexes were protected against a challenge infection with 
strain P-2383. Mice inrounized with P-2383-1 were also protected against 
challenge infections with several P. multocida strains of the serotype 
that killed 100% of the control mice (Table 3). 
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Table 2. Immunogenicity for mice of LPS-protein complexes of 
multocida against challenge exposure with strain P-2383. Each 
mouse received 100 to 200 CPU of the bacterium 
intraperitoneally 
Immunization No. surviving/ no. tested 
None 0/5 
P-9238-1 4/5 
P-9663-1 5/5 
P-9954-1 5/5 
P-10027-1 5/5 
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Table 3. Immunogenicity for mice of a LPS-protein complex, P-2383-1, 
against challenge infections with heterologous P. multocida 
strains of capsular type A and somatic type 3 
Immunization 
Strain challenged Control P-2383-1 
P-9238 0/5^  5/5 
P-9663 0/5 5/5 
P-9954 0/5 5/5 
P-10027 0/5 5/5 
N^o. surviving/ no. tested. 
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DISCUSSION 
We have previously reported that a LPS-protein complex (P-2383-1) 
isolated from a KSCN extract of a P. multocida strain (P-2383; capsular 
type A and somatic type 3) induced resistance in mice to challenge 
infection with the homologous strain (30). P-2383-1 serologically cross-
reacted with PÏ1Î-LPS of the organism, however, KDO was not detected in P-
2383-1 at a protein concentration of 5mg/ml. 
Previous experimentation by other workers has demonstrated the 
presence of LPS in immunogenic P. multocida fractions as determined by 
serologic assays (11, 12, 25, 30) , endotoxic activity (8, 11, 12, 25, 26) 
and chemical methods (8, 12, 22, 26). However, those determinations were 
quite restrictive in relating LPS as a component of the respective 
fractions. Serologic reactions involving polysaccharide antigens are 
widely recognized for cross-reactivity (16, 19). Therefore, cross-
reaction between PW-LPS and immunogenic fractions does not necessarily 
mean the presence of LPS. Toxic activity is a satisfactory indicator of 
the presence of LPS but does not rule out potential toxic materials other 
than LPS present in cell wall materials of bacteria (13) . Fatty acids 
are associated with LPS but are common constituents of the bacterial 
membrane structure (13) . Detection of KDO in P. multocida fractions has 
been used most extensively to determine the presence of LPS; however, 
Rimler et al. (29) reported that the amount of KDO in LPS of somatic 
serotype 3 P. multocida was only approximately 1%. Therefore, detection 
of KDO in an immunogenic fraction of £. multocida may be difficult if LPS 
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represents only minor component of the fraction. 
GC analysis of the P. multocida fractions in this study clearly 
indicated the presence of LPS in the two immunogenic fractions (Fig. 2). 
The presence of typical constituents of the bacterial LPS was 
demonstrated in the chromatograms of the immunogenic fractions. Also, 
these chrcmatograms clearly showed compositional differences between the 
two fractions, which previously have been considered to be similar 
materials since they contained the same protein and carbohydrate content 
(8, 30). This indicates that this GC procedure is not only useful for 
detection of LPS in bacterial fractions but also useful for direct 
comparison of chemical composition of various fractions. The differences 
in ratio of polysaccharide to fatty acid between the immunogenic 
fractions and PW-LPS may be explained by the unique nature of cell wall 
structure of Grant-negative bacteria. The cell wall is a multilayered 
structure including cytoplaanic membrane, a thin rigid layer of 
peptidoglycan and outer manbrane (13, 16). LPS exists in the outer 
leaflet of the double-tracked outer membrane and the fatty acid moiety of 
LPS, lipid A, is responsible for the toxicity. Approximately 50% of the 
LPS is held non-covalently in the membrane and often forms blebs that can 
be easily detached frcm the membrane in exponentially growing bacteria 
and by mild physical and chanical treatments. Therefore, it is possible 
that different extraction methods used for the preparation of the 
bacterial fractions may influence the chemical composition of LPS in the 
products. The exact mechanism of individual reagents used for extraction 
of bacterial fractions is not known. However, a chaotrophic reagent. 
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KSCN, may extract a part of LPS present in the outer membrane such as LPS 
blebs or cleave off sane fatty acids fron lipid A, while phenol-water 
treatment may extract the whole LPS and even the inner leaflet of the 
outer membrane, or some fatty acids frcm the cytoplasmic monbrane. It is 
also possible that the purification process utilized in the preparation 
of the bacterial fractions may have influenced the chemical composition 
of the final products. The PV^LPS was prepared from bacteria washed 
several times by centrifugation and could have resulted in a loss of the 
surface materials of P. multocida. P-2383-1 was isolated frati unwashed 
bacteria and should have resulted in retention of most of the cell 
surface materials. While P-2383-1 obviously contains LPS, there is in 
addition an abundance of proteins and other polysaccharides. Therefore, 
the relative amount of LPS in these two preparations was distinctively 
different. 
The fatty acid content and composition of lipid A is known to 
influence toxicity of LPS (19, 20). The quantity and type of fatty acids 
present in various £. multocida fractions was variant. This may account 
for the differing toxicity of these materials in chicken anbryos. P-
2383-1 was less toxic than PW-LPS. The LPS moiety of P-2383-1 (P-2383-1-
LPS) was more toxic than P-2383-1 but less toxic than PW-LPS. These 
results were expected since only a part of P-2383-1 is LPS and P-2383-1-
LPS contained more carbohydrate than fatty acid in comparison with Ptf-LPS 
(Figs. 1, 2). The variability in relative fatty acid content in these 
respective LPS-containing fractions probably is responsible for differing 
toxicity. 
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P-2383-1 was previously reported to be a single antigenic component 
of the KSCN extract that contained at 25 different antigenic components 
as determined by crossed-immunoelectrophoretic techniques with and an 
antiserum pool prepared from rabbits immunized with whole cell lysate, 
ribosomal-protein complex and KSCN extract of strain P-2383 (30). The 
purpose of SDS-PAGE and Western immunoblot analysis was to find a 
molecular component responsible for induction of immunogenicity in mice, 
however, the results of this study were somewhat disappointing. P-2383-1 
was previously determined to be a single macromolecule (30) v^ ose large 
size was indicated by the inability of P-2383-1 to migrate through the 
polyacrylamide gel. However, silver staining of the gel of P. multocida 
fractions (Figs. 3, 4) indicates that P-2383-1 appeared to be a molecular 
complex that is composed of more than 32 different protein and 
polysaccharide components. Analysis by Vtestern immunoblot (Fig. 5) 
indicated that at least 18 different components from P-2383-1 reacted 
with an antiserum against P-2383-1 that showed a single precipitation 
line with P-2383-1 and two lines with the KSCN extract. 
The protective antigen is probably one of the proteins associated 
with P-2383-1. While P-2383-1-LPS reacted with the antiserum against P-
2383-1, it did not induce immunity that protected mice from challenge 
with P. multocida (see Section III). Alternatively, the LPS may lack 
immunogenicity, a property that is well recognized (27). Phenol-water 
extracted protein from P-2383-1 was also demonstrated to lack 
immunogenicity (see Section III). However, phenol-water treatment may 
have altered some of proteins present in P-2383-1. This assumption would 
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be supported by the fact that about 8 times greater protein concentration 
was required for the protein moiety than for the LPS-protein complex to 
show visible bands in SDS-PAGE and Vfestern immunoblot. Also, a major 
protein band approximately 24 kilodaltons in molecular size apparently 
was altered since the intensity of the band was quite different between 
P-2383-1-PRO and the original complex (Fig. 5). 
The results of the mouse protection study indicated that P-2383-1 
induces substantial cross-protection against different strains of P. 
multocida of the same serotype (Table 3). Also, mice immunized with the 
LPS-protein complexes isolated from different strains were protected 
against P-2383 (Table 2). This might be expected since the LPS-protein 
complexes from different strains were found to contain common antigenic 
components when examined by SDS-PAGE and Wfestern immunoblot (Figs. 3, 4, 
5). Therefore, the LPS-protein complex isolated from a KSCW extract of a 
single strain of P. multocida can potentially provide cross-protective 
immunogenicity at least within strains of capsular type A and somatic 
type 3 that have been most frequently isolated from the cases of bovine 
pneumonic pasteurellosis in the United States (3). 
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SECTION III. IMMUNOLOGIC REACTIVITY OF A LIPOPOLYSACCHARIDE-PROTEIN 
COMPLEX OF TYPE A PASTEURELLA MULTOCIDA IN MICE 
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SUMMARY 
Immunologic reactivity of a lipopolysaccharide (LPS)-protein complex 
isolated from a potassium thiocyanate extract of a Pasteurella multocida 
strain (£. multocida; capsular type A and somatic type 3) was evaluated 
in mice. When the LPS-protein complex was fractionated into LPS and 
protein moieties by phenol-water treatment, both components lacked 
immunogenicity. The protein moiety was extremely blastogenic for mouse B 
cells while the original complex had a limited activity. Although 
hyperimmune serum against the LPS-protein complex protected mice against 
challenge thereby indicating a role for humoral immunity, the LPS-protein 
complex of P. multocida was also found to induce cell-mediated immunity. 
The LPS-protein complex induced a blastogenic response only by the T 
cells from mice inmunized with the same complex while T cells fron other 
mice were not reactive to the complex. This complex also induced a 
delayed type hypersensitivity reaction in the hind footpads of mice 
inmunized with the complex while non-inmunized control mice did not react 
to the complex. When mice immunized with the complex were challenged 
with a facultative intracellular parasite. Salmonella enteritidis, growth 
of the bacterium was suppressed as compared to multiplication of the 
bacteria in control mice. 
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INTRODUCTION 
Pasteurella multocida (P. multocida) is a Granv-negative 
microorganism responsible for economically important diseases in animals 
such as fowl cholera and pneumonic pasteurellosis of cattle (5, 7). The 
scientific and economic importance of P. multocida has led to the use of 
various bacterins for prevention; however, the efficacy of these products 
has been questioned (3, 13, 18, 22). In fact, immunization of cattle 
with Pasteurella bacterins has been demonstrated to be detrimental to the 
health of the animals (3, 18). The questionable efficacy and safety of 
bacterins has led to experimentation with various subcellular fractions 
of the organism in studies of bacterial pathogenesis and in pursuit of a 
better immunogen. 
Lipopolysaccharides (LPS, endotoxin) of many Gram-negative bacteria 
have been demonstrated to play important roles in bacterial infection of 
animals (16, 29). LPS of P. multocida has been observed to evoke a 
variety of endotoxic activities in experimental animals (2, 5, 7). Also, 
many of the £. multocida fractions with demonstrated immunogenicity 
contained LPS as one of their constituents (11, 14, 15, 24, 25, 26, 27). 
At present, immunity against P. multocida infection induced by the 
various LPS-containing fractions is not clearly understood. The chemical 
nature of these fractions responsible for the immunogenicity and the type 
of immunity induced by the fractions is presently unknown. 
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We have been investigating the immunogenic activity of a LPS-protein 
complex isolated from a potassium thiocyanate (KSCN) extract of type A P. 
multocida. The objectives of this study were to find the chemical nature 
of the complex responsible for induction of immunogenicity and to 
determine the type of immunity induced by the complex in mice. 
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MATERIALS AND METHODS 
Organism 
P. multocida strain P-2383 (capsular type A and somatic type 3) was 
used throughout this experimentation. Culture conditions for growth of 
the organism, preparation of a KSCN extract and isolation of a LPS-
protein complex (P-2383-1) from the KSCN extract have been described 
previously (26). 
Fractionation of LPS-Protein Complex 
The LPS-protein complex was fractionated into LPS and protein 
moieties by an extended Wèstphal's phenol-water procedure described by 
Sultzer and Goodman (30). Briefly, P-2383-1 dissolved in 0.32 M 
NaCl/0.01 M tris-HCl buffer was dialyzed against distilled water at 4 C 
before treatment with hot phenol (65 C). The LPS moiety (P-2383-1-LPS) 
was obtained from the water phase while the protein moiety (P-2383-1-PRO) 
was collected from the phenol phase by precipitation with cold ethanol 
(-20 C). Since P-2383-1-PRO was poorly soluble in water, it was 
solubilized by suspending 2 mg (dry weight) in 0.95 ml of distilled water 
and adding 0.05 ml of 0.1 N NaOH. 
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Preparation of multocida LPS 
The phenol-water extracted LPS (PW-LPS) was prepared from strain P-
2383 by the method of Wtestphal and Jann (32) with slight modification as 
described previously (26). 
Chemical Analysis 
P. multocida fractions were analyzed for basic chemical content. 
Total carbohydrate was determined by the phenol-sulfuric acid procedure 
(10) using glucose (Sigma Chemical Co., St. Louis, MO) as a standard. 
Protein content was determined colorimetrically from the reaction of 
protein with Serva blue G dye (Serva Fine Chemicals, Inc., Long Island, 
NY), using bovine serum albumin (Sigma) as a standard (23). 
Immunization and Challenge of Mice 
White Swiss mice of one sex, 8 weeks of age, and at least 20 g in 
weight (Bio-Lab Corp., St. Paul, MN) were used throughout this 
experimentation. Concentration of £. multocida fractions used for 
immunization were; P-2383-1 and P-2383-1-PRO (1.0 mg/ml protein 
concentration) and P-2383-1-LPS (0.5 mg/ml carbohydrate concentration). 
Mice were immunized by the subcutaneous route with 0.1 ml of £. multocida 
fractions for the active protection studies, lymphocyte blastogenesis 
assay, induction of delayed-type hypersensitivity and effect on growth of 
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Salmonella enteritidis (S. enteritidis). To produce hyperimmune serum, 
the immunized mice received a booster injection of 0.1 ml of antigen by 
the same route 2 weeks after the primary immunization. Serum was 
collected 1 week later and 0.2 ml of the serum was injected 
intraperitoneally into normal mice for the passive protection studies. 
The mice were challenged with 0.1 ml of virulent JP. multocida suspension 
intraperitoneally 2 weeks after active immunization or 24 h after passive 
immunization. 
Isolation and Separation of Spleen Cells 
Any one day between 2 to 3 weeks after immunization, mice from each 
group were utilized for collection of serum and isolation of spleen 
cells. The mouse was bled first from the ophthalmic venous plexus and 
then killed. The spleen was removed aseptically and infused with 1 ml of 
RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) containing 2 mM 
L-glutamine and 25 mM N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid 
supplemented with penicillin (Sigma; 100 units/ml) and streptomycin 
(Sigma; 0.1 mg/ml) and 10% fetal calf serum (FCS; Hazleton Research 
Products, Denver, PA). The spleen was minced through a 60-raesh stainless 
steel screen and the screen was rinsed with 3 ml of medium. The spleen 
cell suspension was transferred to a screw cap tube and the debris 
allowed to settle for 10 min. The supernatant was transferred to another 
tube and the cells washed twice with medium by centrifugation at 400 x g 
for 5 min. The pellet was resuspended in 2.5 ml of a filter-sterilized 
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red cell lysing solution containing 0.645 M NH^ Cl, 0.01 M KHCO^ and 0.1 
mM disodium ethylenediamine tetraacetate (EDTA; Sigma). After incubation 
for 10 min in an ice bath with occasional shaking, the suspension was 
centrifuged through a layer of PCS. The supernatant was discarded and 
the pellet was washed twice by centrifugation. The spleen cells were 
counted and standardized to 10^  cells per ml in a phosphate buffered 
saline solution (PBS; pH. 7.2) containing 5% PCS. T and B lymphocytes 
from the spleen cell suspension were separated by a panning procedure 
(34) using a sterile petri dish (100 x 20 mm, 1005 Optilux: Falcon, 
Oxnard, CA) and rabbit anti-mouse immunoglobulins (Igs) obtained from Dr. 
M. J. Wannemuehler, Veterinary Medical Research Institute, Iowa State 
University, Ames, Iowa. Briefly, the Igs were diluted in 10 ml of 0.05 M 
Trizma hydrochloride solution (Sigma), pH 9.5, and sterilized through a 
0.2 um membrane filter (Gelman Sciences Inc., Ann Arbor, MI). The final 
concentration of the Igs was adjusted to 10 ug per ml and 10 ml of the 
solution was poured into the plate. After a 40 min incubation at room 
temperature, the solution was decanted and the plate was washed 4 times 
with 10 ml of PBS and once with 5 ml of PBS containing 1% PCS. Por 
direct binding, 3 ml of the standardized spleen cell suspension was 
poured into each Ig-coated plate with care taken to avoid bubbles. The 
plate was incubated on a level surface at 4 C for 70 min with unattached 
cells redistributed by swirling the plate at the 40 min mark. The 
nonadherent (Ig") cells were removed by swirling and decanting the 
supernatant. Plates were'gently washed 5 times in 10 ml of PBS 
containing 1% PCS. To recover the bound (Ig"*") cells, 5 ml PBS containing 
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5% FCS was added and the entire surface of the plate was flushed by the 
use of a pipet. The Ig~ cells were considered as T cells and Ig"*" cells 
were considered as B cells. Purity of the pan-purified T and B cells was 
determined by a fluorescence microscopy using fluorescein-conjugated goat 
anti-mouse Igs (Cooper Biomedical, Westchesters, PA). 
Mitogens 
Phytohemagglutinin (PHA, 20 ug/ml; Burroughs Welcome, Triangle Park, 
NC), concanavalin A (Con A, 25 ug/ml; Miles Laboratories, Elkhart, IN), 
PW-LPS of P. multocida (20 ug/ml, dry weight), P-2383-1 (100 ug/ml, 
protein concentration), P-2383-l-protein (100 ug/ml, protein 
concentration) and P-2383-1-LPS (40 ug/ml, carbohydrate concentration) 
were used as mitogens. 
Lymphocyte Blastogenesis Assay 
Mitogenic responses of the spleen cells and pan-purified T and B 
lymphocytes were determined in a 96 well tissue culture plate (Costar, 
Cambridge, MA) . Two hundred ul of the standardized cells (2 x 10^ ) and 
25 ul of mitogen or medium were added to each well in triplicate sets. 
After incubation at 37 C in a humidified CO^  incubator for 48 h, 1 uCi of 
[ H]-thymidine (Amersham Corp., Arlington Heights, IL) was added to each 
well. After an additional 16 h incubation the cells were harvested on a 
multiple well harvester (Flow Laboratories, Inc., Rockville, MD) and 
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collected on filter pads. The pads were dried, placed in vials 
containing scintillation fluid and counted in a liquid scintillation 
counter. 
Enzyme-Linked Immunosorbent Assay (ELISA) 
One-tenth ml of P-2383-1-PRO (0.25 ug/ml protein concentration) and 
P-2383-1-LPS (0.5 ug/ml carbohydrate concentration) diluted in a buffer 
containing 15 mM sodiun carbonate and 35 mM sodium bicarbonate (pH 9.6) 
was added to each,well of a flat bottom microplate (Immulon 1; Dynatech 
Laboratories, Inc., Alexandria, VA). The plate was incubated at 37 C for 
24 h and stored at 4 C in a humidified chamber prior to use. The 
antigen-coated plate was rinsed 5 times with a cold washing solution 
containing 0.5 M NaCl, 0.5% Tween 80, 12 mM sodium phosphate monobasic 
and 5 mM sodium phosphate dibasic (pH 7.2). One-tenth ml of serial 1:3 
dilutions of mouse serum was added to all the wells starting from a 1:20 
dilution and the plate was incubated for 2 h at roan temperature. The 
plate was washed again and 0.1 ml of peroxidase conjugated goat anti-
mouse IgG and IgM (Pel-Freez Biologicals, Rogers, AR) was added to each 
well. After incubation for 2 h, the plate was washed again and 0.05 ml 
of a substrate solution (Kirkegaard & Perry Laboratories, inc., 
Gaithersburg, MD) containing hydrogen peroxide and 2.2'-azinodi-(3-
ethylbenzthiazoline sulfonic acid) was added to each well. After 
incubation for 10 min, the enzyme reaction was stopped by adding 0.1 ml 
of 0.5% hydrofluoric acid and the absorption at 405 nm was determined 
104 
with an ELISA reader (Litton Bionetics, Charleston, SC). 
Delayed-Type Hypersensitivity Reaction (DTH) 
DTH of mice against P. multocida fractions was tested by the footpad 
swelling technique described by Gray and Jennings (12). Groups of mice 
were immunized with P. multocida fractions as indicated previously. Two 
weeks after immunization, 0.03 ml of P. multocida fraction (the same 
concentration used for immunization) was injected into a hind footpad of 
one leg using a 27 gauge needle. The same volume of 0.32 M MaCl/0.01 M 
tris-HCl buffer (Sigma) was introduced to a hind footpad of the other leg 
as a control. The mouse footpads were observed at 2, 4, 6, 8 and 18 h 
and the swelling was measured at 1, 2, 3, 4, 5 and 6 days with a dial 
gauge caliper (Fisher Scientific Inc., Itasca, IL). The footpads for 
histological examinations were excised, fixed in 10% formalin, 
decalcified with EDTA and paraffin sections were stained with hematoxylin 
and eosin. 
Effect on Growth of S. enteritidis in Spleen 
A enteritidis strain used in this experimentation was obtained 
from the National Veterinary Services Laboratory, Ames, Iowa. The 
serological cross-reactivity of the organism with P. multocida was 
examined by a slide agglutination test with antisera against whole cells 
and P-2383-1 of P. multocida. No serological cross-reaction was observed 
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between the two organisms. The organism was passed five times through 
mice with reisolation frcrn the spleen and the final isolate was grown for 
4 h at 37 C in yolk material from 6-day old anbryonated chicken eggs. 
The culture was divided into aliquots and stored at -70 C. For the 
preparation of bacterial culture, the infected yolk material was thawed, 
inoculated on a 5% bovine blood agar plate and incubated for 24 h at 37 
C. One colony was transferred to 30 ml of trypticase soy broth (TSB; 
Becton Dickinson and Co., Cockeysville, MD) and incubated for 18 h at 37 
C. One-tenth ml of the culture was transferred to 5 ml TSB and incubated 
another 4 h. Mice were injected with approximately 1.5 x 10^  colony 
forming units (CPU) of the bacteria (spectrophotometrically adjusted and 
plate counted) by the intraperitoneal route. To obtain a growth curve of 
S. enteritidis in the spleen of normal mice, groups of mice were 
sacrified at 1, 3, 5, 7 and 10 days after infection with the bacteria. 
The spleens were aseptically ranoved and placed in homogenizer tubes 
containing 5 ml of PBS. They were dispersed with a teflon pestle, 
serially diluted and plated on a well-dried MacConkey agar plate in 
duplicate. Colony counts were conducted after incubation at 37 C for 18 
h. 
To determine the effect of a LPS-protein complex of £. multocida (P-
2383-1) and fractions of the complex on growth of enteritidis, groups 
of either 3 or 5 mice were treated as follows; Day 0, primary 
immunization subcutaneously or no treatment; Day 14, secondary 
immunization by the footpad route or no treatment; Day 21, challenge 
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infection with enteritidis intraperitoneally; Days 22 or 26, 
determination of CFU per spleen. 
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RESULTS 
Chemical Analysis 
The carbohydrate and protein content of P-2383-1 and its phenol-
water extracted fractions are listed in Table 1. P-2383-1 contained 12% 
carbohydrate and 27% protein, P-2383-1-LPS contained 50% and 7%, and P-
2383-1-PRO contained less than 2% and 100% respectively. 
Immunogenicity 
The non-fractionated LPS-protein complex {P-2383-1) induced 
substantial protection in mice against a challenge with strain P-2383; 
however, fractions (P-2383-1-LPS, P-2383-1-PRO) obtained from the complex 
and a mixture of the two fractions failed to provide substantial 
protection (Table 2). The protein moiety (P-2383-1-PRO) mixed with 20% 
alixninum hydroxide induced a degree of protection, but the surviving mice 
were clinically ill and has not completely recovered 10 days after the 
challenge, the last day of observation. 
Blastogenesis Assay of Mouse Spleen Cells 
Spleens from mice immunized with P-2383-1 were hyperplastic and 
yielded approximately 180 million cells while spleens from the control 
mice and mice immunized with other antigens were normal in size and 
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Table 1. Chemical analysis of a LPS-protein complex of P. multocida (P-
2383-1) and fractions of the complex 
Antigens Carbohydrate (%) Protein (%) 
P-2383-1 
P-2383-1-LPS 
P-2383-1-PRO 
12 
50 
< 2 
27 
7 
100 
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Table 2. Immunogenicity for mice of a LPS-protein complex of P. 
multocida (P-2383-1) and its fractions against challenge 
exposure with strain P-2383. Each mouse received 100 to 200 
CFU 
Immunization No. surviving/ No. tested 
Control 0/10 
P-2383-1 11/11 
P-2383-1-PRO 0/5 
P-2383-1-PRO + 20% Aluminum hydroxide 4/10^  
P-2383-1-LPS 0/5 
P-2383-1-PRO + P-2383-1-LPS 0/5 
\he surviving mice were clinically ill up to 10 days. 
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yielded approximately 120 million cells. The recovery of T and B cells 
by the panning procedure was approximately 35% each of the total spleen 
cells. Membrane fluorescence indicated that at least 97% of the cells in 
the T and B cell preparations were homogeneous. The optimal mitogenic 
concentrations of P. multocida fractions were determined and used in 
blastogenesis assays except for P-2383-1-PRO. The protein content of P-
2383-1-PRO was adjusted to equivalence with that of P-2383-1 since a 
higher concentration was extremely blastogenic to B cells. As indicated 
in Table 3, the mitogenic responses of non-separated spleen cells to P. 
multocida fractions were not different between the control mice and mice 
immunized with P-2383-1. P-2383-1 induced an extremely significant 
mitogenic response by T cells isolated from the mice immunized with P-
2383-1 while other £. multocida fractions did not (Table 4). The LPS-
containing fractions of P. multocida were found to induce non-specific 
blastogenic responses of B cells (Table 5). Although the protein content 
of P-2383-1-PRO was the same as P-2383-1, P-2383-1-PRO induced a much 
greater blastogenic response of B cells than the original canplex (Table 
5) . 
Antibody Titer and Passive Protection 
Antibody titers of sera obtained from the mice used for the 
blastogenesis assay are listed in Table 6. The sera from the mice 
immunized with P-2383-1 had the highest antibody titers to both ELISA 
antigens. The sera from the mice immunized and boosted with P-2383-1-PRO 
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Table 3. Blastogenic responses of spleen cells isolated from mice 
immunized with a LPS-protein complex antigen of P. multocida 
(P-2383-1) or non-immunized control mice 
Iirmunizing preparation 
Mitogen Control P-2383-1 
None 
Phytohemagglutinin 
Concanavalin A 
P-2383 PW-LPS 
P-2383-1 
P-2383-1-PRO 
P-2383-1-LPS 
C^ounts per minute. Mean + SD (n = 3) . 
448 + 55^  
27,675 + 5,756 
32,475 + 6,624 
9,273 + 136 
7,550 + 1,148 
21,322 + 3,257 
5,016 + 1,845 
377 + 19 
19,240 + 4,910 
18,534 + 772 
7,710 + 549 
9,728 +1,383 
15,217 + 4,595 
6,458 + 403 
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Table 4. Blastogenic responses of pan-purified T (Ig~) cells from mice 
immunized with a LPS-protein complex antigen of P. multocida 
(P-2383-1) or fractions of the complex 
Immunizing Preparation 
Mitogen Control P-2383-1 P-2383-1-PRO P-2383-1-LPS 
None 1.2 + 0.5^  1.4 + 0.2 1.2 + 0.3 1.4 + 0.4 
PHA 65.5 + 7.8 73.1 + 18,2 63.8 + 16.4 76.4 + 6.7 
Con A 90.8 + 7.7 73.6 + 11.0 66.4 + 19.8 76.6 + 14.5 
PW-LPS 4.9 + 0.4 4.5 + 0.4 4.7 + 1.7 4.1 + 0.6 
P-2383-1 5.1 + 0.2 20.1 + 
*** 
7.5 4.9 + 2.0 3.6 + 0.8 
P-2383-1--PRO 5.3 + 0.4 5.8 + 1.5 8.1 + 3.4 6.8 + 2.9 
P-2383-1-•LPS 2.3 + 0.1 2.7 + 0.7 2.8 + 0.4 3.4 + 0.5 
x^ 10^  counts per minute, mean SD (n = 6). 
p < 0.005; level of statistical significance as compared to the 
control (Student's T-test). 
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Table 5. Blastogenic responses of pan-purified B (Ig*) cells from mice 
immunized with a LPS-protein complex antigen of P. multocida 
(P-2383-1) or fractions of the complex 
Immunizing Preparation 
Mitogen Control P-2383-1 P-2383-1-PRO P-2383-1-LPS 
None 1.0 + 0.1^  0.9 + 0.2 1.0 + 0.2 1.0 + 0.1 
PHA 3.7 + 0.2 2.3 + 1.2 3.0 + 0.8 3.8 + 0.6 
Con A 2.1 + 0.2 1.5 + 1.0 1.5 + 0.4 3.0 + 0.9 
PW-LPS 35.9 + 4.7 41.4 + 11.5 46.8 + 11.9 63.5 + 6.1*** 
P-2383-1 30.0 + 6.1 30.4 + 9.0 21.4 + 6.4 28.0 + 8.4 
P-2383-1-•PRO 68.0 + 8.0 69.3 + 11.5 79.1 + 21.3 87.2 + 17.9 
P-2383-1-•LPS 13.8 + 2.3 14.8 + 4.5 15.5 + 5.3 23.5 + 3.7*** 
\ 10^  counts per minute, mean SD (n = 5). 
p < 0.005; level of statistical significance as compared to the 
control (Student's T-test). 
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Table 6. Antibody titers in ELISA of the sera obtained from mice used 
for lymphocyte blastogenesis assays 
ELISA Antigen 
Antiserum^  P-2383-1-PRO P-2383-1-LPS 
Control 1:60^  1:60 
P-2383-1 1:14,580 1:14,580 
P-2383-1-PRO 1:1,620 1:180 
P-2383-1-LPS 1:4,860 1:4,860 
S^erum obtained from mice immunized with different antigens. 
A^verage antibody titer (n = 6). 
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has a mean antibody titer of 1:4,860 to the same antigen. The sera from 
the mice immunized and boosted with P-2383-1-LPS had a mean antibody 
titer of 1:43,740 to the protein antigen (Table 7). Only the serum from 
the mice immunized and boosted with P-2383-1 protected mice against £. 
multocida infection although serum from mice immunized and boosted with 
P-2383-1-LPS had an equivalent antibody titer (Table 7). 
Induction of DTH 
Only mice immunized with P-2383-1 developed DTH when the same 
antigen was introduced into the hind footpad. Injection of P-2383-1 as 
well as other antigens into footpads of normal mice or mice immunized 
with other antigens induced a tanporary swelling (up to 2.8 irm) at 24 h 
and the footpads returned to normal size (2.2 mm) by 48 h. The injection 
of P-2383-1 into footpads of the mice immunized with P-2383-1 induced a 
swelling that was visible at 18 h after the injection, reached peak 
swelling (up to 4.7 nm thick) at 48 h, and then slowly subsided returning 
to normal thickness by 7 to 10 days (Fig. 1). 
Histological examination of footpad tissue revealed cellular 
infiltration characteristic of the typical DTH response in mice. At 24 
h, there were focally-intense cellular infiltrates composed primarily 
neutrophils, but occasionally macrophages (Fig. 2-A). Increased numbers 
of mononuclear cells had diffusely infiltrated into the footpads at 48 h 
and the ratio of neutrophils to mononuclear cells in the lesion was 
approximately 50:50 (Fig. 2-B). At 72 h, cellular infiltration was 
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Table 7. Resistance of mice against challenge infection with P. 
multocida strain P-2383 following intraperitoneal 
administration of mouse antiserum 
ELISA Antigen Challenge Infection 
Antiserum® P-2383-1-PRO P-2383-1-LPS 98 c.f.u. 980 c.f.u. 
Negative control 1:60^  1:60 0/5^  
P-2383-1 1:43,740 1:14,580 5/5 5/5 
P-2383-1-LPS 1:43,740 1:4,860 0/5 
^Serum obtained fron mice immunized with different antigen. 
^Antibody titer. 
^No. of mice surviving/ no. of mice tested. 
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FIG. 1. Footpad enlargement of mice immunized with P-2383-1 following 
administration of the same antigen was introduced into the 
footpad 2 weeks post-immunization (n = 10) 
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W i J 
PIG. 2. Photographs showing histopathologic changes in the footpads of 
mice immunized with P-2383-1. Tissues were obtained at various 
times following introduction of P-2383-1 into the footpad at 2 
weeks post-immunization: A, 24 h; B, 48 h; C, 72 h; D, 6 days 
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predominantly composed of mononuclear cells, large foamy macrophages and 
lymphocytes (Fig. 2-C). At day 6, few neutrophils were present but 
mononuclear cells were still in residence (Fig. 2-D) 
Growth of S. enteritidis in the Spleen 
A growth curve of enteritidis in the spleen of normal mice was 
determined. The initial accumulation of the bacteria in the spleen at 
day 1 was slighly less than the inoculum, but thereafter the organisms 
grew logarithmically up to day 5 (Fig. 3) . By 7 to 10 days, there was no 
further dramatic increase in the number of bacteria; however, hyperplasia 
of the spleen was noted. At day 14, multifocal necrosis in the spleen 
was observed although the mice were clinically healthy. Day 5 (log phase 
growth) was chosen to evaluate the iinmunizing effect of the LPS-protein 
complex, P-2383-1, on growth of S. enteritidis in spleen. There was no 
difference at day 22 (one day after the challenge) in bacterial counts in 
spleens of the control mice and mice immunized with P-2383-1 while highly 
significant differences were observed at day 26 (Tables 8 and 9) . 
Inoculation of P-2383-1 into footpads of normal mice also induced a 
degree of immunity indicated by suppression of bacterial growth in the 
spleen (Table 9). Fractions of P-2383-1 failed to induce suppression 
equivalent to P-2383-1. 
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Days 
FIG. 3. Growth of enteritidis in the spleen of normal mice. Each 
mouse received 1.7 x 10^  CFU of the bacterium intraperitoneally 
(n = 5) 
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Table 8. Growth of S. enteritidis in the spleens of mice iimunized with 
P-2383-1 or non-imnunized control mice. Each mouse received 
1.7 X lO'^  CFU of the bacterium intraperitoneally at day 21 
CFU^  
Primary Secondary 
immunization^  immunization*^  Day 22 (n = 5) Day 26 (n = 5) 
None None 8.2+2.6 x 10^  1.3 ^  0.6 x 10® 
P-2383-1 P-2383-1 7.3 + 1.6 x 10^  2.7 + 1.4 x 10*** 
Values indicate CFU per spleen, mean +_ SD. 
M^ice were immunized subcutaneously at day 0. 
M^ice were immunized via footpad at day 14. 
p < 0.005; level of statistical significance as compared to the 
non-immunized control (Student's T-test). 
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Table 9. Growth of S.' enteritidis in spleens of non-immunized control 
mice and mice iitmunized with P-2383-1 or fractions of P-2383-1. 
Each mouse received 1.5 x 10^  CFU of the bacterium 
intraperitoneally at day 21 
Primary Secondary 
immunization^  immunization^  CFU° 
None None (n = 5) 6.4 + 2.1 X 10^  
None P-2383-1 (n = : 5) 1.4 + 0.7 X 
None P-2383-1-LPS (n = 5) 4.5 + 1.1 X 10^  
None P-2383-1-PRO (n = 5) 5.9 + 2.3 X 10^  
P-2383. -1 None (n = 5) 2.7 + 1.8 X 104*** 
P-2383--1 P-2383-1 (n = 5) 1.8 + 0.9 X 104*** 
P-2383--1-LPS P-2383-1-LPS (n = 3) 2.0 + 0.4 X 
P-2383--l-PRO P-2383-1-PRO (n = 3) 2.6 + 1.1 X 
M^ice were immunized subcutaneously at day 0. 
M^ice were immunized via footpad at day 14. 
"Values indicate CFU per spleen, mean SD. 
p < 0.005; level of statistical significance as compared to the 
non-immunized control (Student's T-test). 
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DISCUSSION 
We have previously reported that a LPS-protein conplex isolated from 
a KSCN extract of a P. multocida strain (P-2383; capsular type A and 
somatic type 3) induced resistance in mice to challenge with the 
homologous strain (26) . Clinical signs in these mice following challenge 
infection suggested that the purified LPS-protein complex, P-2383-1, 
would be a better immunogen than the original KSCN extract (26). In this 
study, the immunogenic reactivity of P-2383-1 was further characterized 
by fractionating it into LPS (P-2383-1-LPS) and protein (P-2383-1-PRO) 
moieties by phenol-water treatment. 
This study indicated that PW-LPS of £. multocida, P-2383-1 and its 
LPS moiety P-2383-1-LPS can induce non-specific blastogenic responses of 
mouse B cells (Table 5). This confirmed previous observations that LPS 
of Gram-n^ ative bacteria is a potent mitogen for mouse B cells (21, 30, 
31). The results also indicated that P-2383-1-PRO, at the same protein 
concentration as P-2383-1, was extremely blastogenic for B cells while 
the original complex had more limited mitogenic activity. Similar 
results have been observed in the studies on classical endotoxin proteins 
(or lipid A-associated proteins) that have been fractionated from butanol 
or trichloroacetic acid-extracted LPS of Escherichia coli and Salmonella 
typhosa by the phenol-water procedure (21, 30, 31). In addition, both P-
2383-1-PRO and endotoxin proteins were poorly soluble in water, but 
readily soluble in diluted alkali or phenol (30). Also, they were 
composed of several distinctive components with molecular weights from 8 
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to 40 kilodaltons (31, see Section II) and known to represent major 
proteins found on the outer cell manbrane (31) . This would indicate that 
the protein component of P-2383-1 may have similar characteristics to the 
endotoxin protein of enterobacteria. The mechanism of blastogenic 
response of B cells to the endotoxin protein is not clear; however, the 
endotoxin protein has been reported to exhibit various immunostimulatory 
activities (21, 31). These activities included activation of B cells, 
macrophages, neutrophils and mast cells, non-specific resistance to a 
bacterial infection in mice, and induction of interferon both in vitro 
and in vivo. 
In contrast to classical endotoxin protein of enterobacteria, P-
2383-1-PRO was inconsistent in its immunologic activity. This protein 
material lacked immunogenicity in mice as determined by challenge 
infection (Table 2) and failed to induce DTH responses and non-specific 
resistance to S. enteritidis infection (Table 9). This would indicate 
that the protein component is not the same material as endotoxin protein 
of enterobacteria although both exhibit similar chemical and physical 
characteristics. It is possible that phenol-water treatment of the LPS-
protein carpiex may denature the protein or alter the antigenic 
determinant(s) of the complex associated with immunogenicity. Analysis 
of the complex and its fractions by SDS-PAGE and Western immunoblot 
indicated that the complex contained more and stronger protein bands than 
its protein component even at 8 times less protein concentration than the 
protein component (see Section II). In addition, a major protein band 
approximately 24 kilodaltons in size present in the complex was 
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apparently altered since several weak bands were found rather than the 
single band. However, there is clear evidence that immunogenic 
specificity of the LPS-protein complex is associated with the protein 
moiety. Since P-2383-1-PRO mixed with 20% aluminum hydroxide provided a 
degree of protection (Table 2), this material apparently requires an 
adjuvant. The reason for lack of immunizing activity of this material 
may be due to the absence of LPS that is known to be a potent adjuvant 
(16, 21). Adjuvant activity of the LPS is indicated by the finding that 
a high titer of antibody was induced against the protein moiety when P-
2383-1-LPS was used for immunization (Table 6). 
The results of our experimentation on immune mechanisms involved in 
protection of mice against £. multocida infection indicate that the LPS-
protein complex of £. multocida can induce both humoral and cell-mediated 
irrmunity in mice. Protection of mice against challenge by passive 
transfer of immune serum against P-2383-1 would support the induction of 
humoral immunity (Table 7). However, specificity of antibody is of great 
importance. Antiserum against P-2383-1 provided protection while 
antiserum against P-2383-1-LPS did not although both antisera had a 
similar antibody titer. Protection of mice against P. multocida 
infection by passive immunization has also been danonstrated by other 
workers (5, 6, 8, 15, 33). Since the bacteria were seldom found in parts 
of the body of the passively immunized mice other than the site of 
inoculation (6, 8), Collins and Woolcock suggested that the primary role 
of antibody is inhibition of the rapid spread of the organism to the 
blood stream and other reticuloendothelial organs. 
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Evidence for induction of cell-mediated immunity by P-2383-1 was 
found in observations of the blastogenic response of T cells to P-2383-1, 
DTH and inhibition of growth of S. enteritidis in the immunized mice. 
The mitogenic response of the pan-purified T cells from mice immunized 
with P-2383-1 (Table 4) indicated that T cells were sensitized to this 
antigen although the subpopulation of responding T cells is not known. 
DTH reactions in the footpads of mice immunized with P-2383-1 is further 
evidence of cell-mediated ittmunity. The size and duration of swelling 
and histological changes in the footpad were very similar to the DTH 
reaction induced by Mycobacterium tuberculosis-purified protein 
derivative (12, 17). Since mice can suppress growth of the facultative 
intracellular parasites including Listeria monocytogenes (L. 
monocytogenes), Brucella abortus and enteritidis by cell-mediated 
mechanisms, the suppressive effect of P-2383-1 on growth of 
enteritidis, which has no serologic relationship with P-2383-1, would 
also support the induction of cell-mediated immunity by the LPS-protein 
coTiplex of P. multocida (Tables 8 and 9) . However, these findings 
contradict the explanation of Collins and Woolcock on immune mechanisms 
of mice against P. multocida infection. They found that transfer of 
peritoneal or spleen cells from immune mice to normal mice 1 h before 
challenge did not provide protection and the cellular response of the 
passively immunized mice to the P. multocida organisms was predominantly 
polymorphonuclear in nature. Based on these findings, they suggested 
that immunity to P. multocida infection in mice is primarily humoral in 
nature. However, they also found that hyperimmune serum did not 
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influence in vitro bactericidal activity of peritoneal cells from normal 
and immune mice. Also, the inoculated bacteria multiplied for a long 
period of time (14 days) at the site of infection in mice that received 
hyperimmune serum without losing virulence. Recent studies on acquired 
resistance to L. monocytogenes in mice by Campbell and her colleagues may 
explain contradictory observations on immune mechanisms involved in 
protection of mice against P. multocida infection. For many years, the 
acquired resistance in mice to a facultative intracellular bacterium such 
as L. monocytogenes was thought to be a systemic activation of 
mononuclear phagocyte bactericidal activity (19, 20). However, 
Czuprynski et al. (9) suggested that the increased mobilization of 
neutrophils and mononuclear phagocytes into the site of infection is of 
prime importance in resistance to listeriosis. They came to this 
conclusion since they could demonstrate no difference in bactericidal 
activities of the phagocytic cells from normal and immune mice. Also, 
the immune mice were able to recruit rapidly a large number of the 
phagocytic cells at the site of infection. Similar results have been 
found for other facultative intracellular parasites such as S. 
enteritidis and Brucella abortus (P. A. Campbell, Saninar, Annu. Meet. 
Am. Soc. Microbiol. 1986, Session 80). However, the ability of the 
immune mice to accumulate neutrophils and monocytes at the site of 
infection was credited to release of lymphokines by T cells. This would 
indicate a role for the cell-mediated immunity. Like the facultative 
intracellular parasites, P. multocida may be eliminated by neutrophils 
and macrophages if large numbers of these cells were present at the site 
128 
of infection. However, mice may not recruit these phagocytic cells at 
the site of P. multocida infection without induction of cell-mediated 
immunity (1). The induction of cell-mediated immunity, i.e., production 
of lymphokines by T cells, may require significant time and appropriate 
antigenic stimulation. Antibody against the organism may provide these 
requirements by inhibiting the spread of the organism rapidly throughout 
the body while certain surface materials, such as the LPS-protein 
complex, detached from the bacteria may serve as a stimulatory agent for 
later development of cell-mediated immunity. 
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GENERAL SUMMARY 
The experimentation reported in this dissertation includes three 
subjects; 1) determination of the chemical composition of Pasteurella 
multocida (P. multocida) lipopolysaccharides (LPS) in comparison with the 
chemical composition of LPS of several Gram-negative bacterial pathogens; 
2) characterization of a LPS-protein complex isolated from a potassium 
thiocyanate (KSCN) of P. multocida organism; 3) examination of the 
immunologic reactivity of the LPS-protein complex in mice. 
Chanical composition of LPS of £. multocida and several other Gram-
negative bacterial pathogens were analyzed by methanolysis, 
trifluoroacetylation and gas chromatography (GC) on a fused-silica 
capillary column. The GC analysis indicated that LPS prepared frcm a 
strain of £. multocida by phenol-water (PW) or trichloroacetic acid (TCA) 
extraction w^ re quite different in chemical composition. However, LPS 
prepared from Salmonella enteritidis by the two extraction methods were 
very similar. PW-LPS extracts from different Pasteurella strains of a 
serotype had essentially identical GC patterns. Endotoxic LPS extracted 
from 16 different serotypes of multocida by PW or by phenol-
chloroform- petroleum ether procedures yielded chromatograms indicating 
similar composition of the fatty acid moieties but minor differences in 
carbohydrate content. When the chemical composition of endotoxic LPS 
extracted from several Gram-negative bacteria (P. multocida, Pasteurella 
haemolytica, Haemophilus somnus, Actinobacillus ligniersii. Brucella 
abortus, Treponema hyodysenteriae, Escherichia coli, Bacteroides 
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fragilis, Salmonella abortus equi and Salmonella enteritidis) were 
examined y each bacterial LPS showed a unique GC pattern. The 
carbohydrate constituents in LPS of various Gram-negative bacteria were 
quite variable not only in the 0-specific polysaccharide but also in the 
core polysaccharide. The LPS of closely related bacteria shared more 
fatty acid constituents with each other than with unrelated bacteria. 
When the chemical composition of the LPS-protein complex isolated 
from the KSCN of a P. multocida (strain P-2383, capsular type A and 
somatic type 3) was analyzed by GC, this complex was found to contain 
most of chemical constituents characteristic of LPS extracted by the PW 
method from the whole bacterium. However, there apparently was more 
carbohydrate than fatty acid in the complex in contrast to LPS in which 
fatty acid seemed to be in excess. When toxicity of the complex was 
evaluated in 10-day-old chicken embryos, the complex was less toxic (LD^ g 
= 12.72 ug) than the purified LPS (LD^ Q = 0.44 ug). The LD^Q of the LPS 
moiety extracted from the complex was 5.24 ug. Composition of the 
coTiplex was analyzed by SDS-PAGE with silver staining and Vfestern 
immunoblot. The complex did not migrate through the polyacrylamide gel 
unless dissociated with SDS. The complex dissociated with SDS contained 
more than 32 different protein and polysaccharide components; at least 18 
components reacted with an antiserum against the catiplex. There was no 
significant compositional variation between the complexes from different 
strains, but quantitative differences in individual components were 
noted. When cross-protectivity of the complex was evaluated in mice, 
this complex provided substantial protection not only against the 
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homologous bacterium but also against different P. multocida strains of 
the same serotype. LPS-protein complexes isolated by the same method 
from other strains also induced protection against a challenge with P-
2383. 
Immunologic reactivity of the complex was evaluated in mice by 
fractionating the complex into LPS and protein moieties by PW treatment. 
Both PW extracted components lacked immunogenicity in mice. The protein 
moiety was extremely blastogenic for mouse B cells while the original 
complex had limited activity. Although hyperimmune serum against the 
LPS-protein complex protected mice against challenge thereby indicating a 
role for humoral immunity, the LPS-protein conplex of P. multocida was 
also found to induce cell-mediated immunity. The LPS-protein complex 
induced a blastogenic response by T cells from mice immunized with the 
same complex while T cells from other mice were not reactive to the 
complex. This complex also induced a delayed type hypersensitivity 
reaction in the hind footpads of mice immunized with the complex while 
nonimmunized control mice did not react. When mice immunized with the 
complex were challenged with a facultative intracellular parasite, 
Salmonella enteritidis, growth of the bacterium was suppressed as 
compared to multiplication of the bacteria in control mice. 
For many years, immunity to multocida infection in animals has 
been thought to be primarily humoral in nature. This conclusion was 
based on findings frcxn experimental infections with P. multocida in 
laboratory animals including relatively successful protection by passive 
immunization, correlation between serum antibody titer and degree of 
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protection, and failure of protection by active transfer of sensitized 
cells. However, the increased serum antibody titer in cattle immunized 
with P. multocida bacterins has been demonstrated to have no relationship 
with protection of the animal against the disease. This inconsistencies 
may be explained by the differences in animals (cattle versus 
experimental animals such as mice), between systemic and local 
respiratory immune system, or by the nature of antigen including 
specificity of the antigen and presence of competitive antigens or 
deterimental factors. 
The possibility exists that another type of immunity, i.e., cell-
mediated immunity, is more important in prevention of the disease in 
cattle. This study on characterization of the LPS-protein complex 
indicated that the complex induced not only honorai but also cell-
mediated immunity. Also, the complex contained LPS which is known to 
exhibit a variety of immunostimulatory activities in a host including 
adjuvanticity. In addition, the complex isolated a strain of £. 
multocida was found to induce cross-protection against different strains 
of capsular type A and somatic type 3 which has been most frequently 
isolated from the cases of bovine pneumonic pasteurellosis in North 
America. There is now a need to examine the ûtimunogenicity of this 
complex as a potential immunizing agent against £. multocida infection in 
cattle. 
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